References

Adam, D, and K Fehnle. 2008. “Safety and effectiveness against respiratory tract infections for pneumococcal conjugate vaccine co-administered with routine vaccine combinations.” Vaccine 26 (47): 5944–51. https://doi.org/10.1016/j.vaccine.2008.08.058.

Ahmed, Sameer, Nina L Shapiro, and Neil Bhattacharyya. 2014. “Incremental health care utilization and costs for acute otitis media in children.” The Laryngoscope 124 (1): 301–5. https://doi.org/10.1002/lary.24190.

Alicino, Cristiano, Chiara Paganino, Andrea Orsi, Matteo Astengo, Cecilia Trucchi, Giancarlo Icardi, and Filippo Ansaldi. 2017. “The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on hospitalization for pneumonia in children: A systematic review and meta-analysis.” Vaccine 35 (43): 5776–85. https://doi.org/10.1016/j.vaccine.2017.09.005.

Andersen, P. K., and R. D. Gill. 1982. “Cox’s Regression Model for Counting Processes: A Large Sample Study.” The Annals of Statistics 10 (4): 1100–1120. https://doi.org/10.1214/aos/1176345976.

Andrade, Ana Lucia, Eliane T Afonso, Ruth Minamisava, Ana Luiza Bierrenbach, Elier B Cristo, Otaliba L Morais-Neto, Gabriela M Policena, Carla M. A. S. Domingues, and Cristiana M Toscano. 2017. “Direct and indirect impact of 10-valent pneumococcal conjugate vaccine introduction on pneumonia hospitalizations and economic burden in all age-groups in Brazil: A time-series analysis.” Edited by Philip C Hill. PLOS ONE 12 (9): e0184204. https://doi.org/10.1371/journal.pone.0184204.

Andrade, Ana Lucia, Ruth Minamisava, Gabriela Policena, Elier B. Cristo, Carla Magda S. Domingues, Maria Cristina de Cunto Brandileone, Samanta Cristine Grassi Almeida, Cristiana Maria Toscano, and Ana Luiza Bierrenbach. 2016. “Evaluating the impact of PCV-10 on invasive pneumococcal disease in Brazil: A time-series analysis.” Human Vaccines & Immunotherapeutics 12 (2): 285–92. https://doi.org/10.1080/21645515.2015.1117713.

Andrade, Luiz Flavio, Grèce Saba, Jean-Damien Ricard, Jonathan Messika, Jacques Gaillat, Pierre Bonnin, Christian Chidiac, et al. 2018. “Health related quality of life in patients with community-acquired pneumococcal pneumonia in France.” Health and Quality of Life Outcomes 16 (1): 28. https://doi.org/10.1186/s12955-018-0854-6.

Ansaldi, F, L Sticchi, P Durando, R Carloni, P Oreste, M Vercelli, P Crovari, and G Icardi. 2008. “Decline in Pneumonia and Acute Otitis Media after the Introduction of Childhood Pneumococcal Vaccination in Liguria, Italy.” Journal of International Medical Research 36 (6): 1255–60. https://doi.org/10.1177/147323000803600612.

Arason, V A, K G Kristinsson, J A Sigurdsson, G Stefánsdóttir, S Mölstad, and S Gudmundsson. 1996. “Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study.” BMJ (Clinical Research Ed.) 313 (7054): 387–91. https://doi.org/10.1136/bmj.313.7054.387.

Arason, Vilhjalmur A., Johann A. Sigurdsson, Karl G. Kristinsson, Linn Getz, and Sigurdur Gudmundsson. 2005. “Otitis media, tympanostomy tube placement, and use of antibiotics.” Scandinavian Journal of Primary Health Care 23 (3): 184–91. https://doi.org/10.1080/02813430510031298.

Arason, Vilhjalmur A, Johann A Sigurdsson, Karl G Kristinsson, and Sigurdur Gudmundsson. 2002. “Tympanostomy tube placements, sociodemographic factors and parental expectations for management of acute otitis media in Iceland.” The Pediatric Infectious Disease Journal 21 (12): 1110–5. https://doi.org/10.1097/01.inf.0000040702.00373.95.

Arguedas, A., K. Kvaerner, J. Liese, A. G.M. Schilder, and S. I. Pelton. 2010. “Otitis media across nine countries: Disease burden and management.” International Journal of Pediatric Otorhinolaryngology 74 (12): 1419–24. https://doi.org/10.1016/j.ijporl.2010.09.022.

Attema, Arthur E., Werner B. F. Brouwer, and Karl Claxton. 2018. “Discounting in Economic Evaluations.” PharmacoEconomics 36 (7): 745–58. https://doi.org/10.1007/s40273-018-0672-z.

Austin, D J, K G Kristinsson, and R M Anderson. 1999. “The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance.” Proceedings of the National Academy of Sciences of the United States of America 96 (3): 1152–6. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=15366{\&}tool=pmcentrez{\&}rendertype=abstract.

Austrian, R, R M Douglas, G Schiffman, A M Coetzee, H J Koornhof, S Hayden-Smith, and R D Reid. 1976. “Prevention of pneumococcal pneumonia by vaccination.” Transactions of the Association of American Physicians 89: 184–94. http://www.ncbi.nlm.nih.gov/pubmed/14433.

Austrian, Robert. 1964. “Pneumococcal Bacteremia with Especial Reference to Bacteremic Pneumococcal Pneumonia.” Annals of Internal Medicine 60 (5): 759. https://doi.org/10.7326/0003-4819-60-5-759.

———. 1981. “Pneumococcus: the first one hundred years.” Reviews of Infectious Diseases 3 (2): 183–9. https://doi.org/10.1093/clinids/3.2.183.

———. 1999. “A brief history of pneumococcal vaccines.” Drugs & Aging 15 Suppl 1: 1–10. https://doi.org/10.2165/00002512-199915001-00001.

Backhaus, Erik, Stefan Berg, Rune Andersson, Gunilla Ockborn, Petter Malmström, Mats Dahl, Salmir Nasic, and Birger Trollfors. 2016. “Epidemiology of invasive pneumococcal infections: manifestations, incidence and case fatality rate correlated to age, gender and risk factors.” BMC Infectious Diseases 16 (1): 367. https://doi.org/10.1186/s12879-016-1648-2.

Baraibar, Román. 1997. “Incidence and risk factors of acute otitis media in children.” Clinical Microbiology and Infection : The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 3 Suppl 3: S13–S22. https://doi.org/10.1016/S1198-743X(14)64947-8.

Belgorodski, Natalia, Matthias Greiner, Kristin Tolksdorf, and Katharina Schueller. 2017. RriskDistributions: Fitting Distributions to Given Data or Known Quantiles. https://CRAN.R-project.org/package=rriskDistributions.

Bennett, Jonathan E., Walton Sumner, Stephen M. Downs, and David M. Jaffe. 2000. “Parents’ Utilities for Outcomes of Occult Bacteremia.” Archives of Pediatrics & Adolescent Medicine 154 (1): 43–48. https://doi.org/10-1001/pubs.Pediatr Adolesc Med.-ISSN-1072-4710-154-1-poa9043.

Ben-Shimol, Shalom, Noga Givon-Lavi, Eugene Leibovitz, Simon Raiz, David Greenberg, and Ron Dagan. 2014. “Near-Elimination of Otitis Media Caused by 13-Valent Pneumococcal Conjugate Vaccine (PCV) Serotypes in Southern Israel Shortly After Sequential Introduction of 7-Valent/13-Valent PCV.” Clinical Infectious Diseases 59 (12): 1724–32. https://doi.org/10.1093/cid/ciu683.

———. 2016. “Impact of Widespread Introduction of Pneumococcal Conjugate Vaccines on Pneumococcal and Nonpneumococcal Otitis Media.” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 63 (5): 611–8. https://doi.org/10.1093/cid/ciw347.

Berg, Are Stuwitz, Christopher Stephen Inchley, Audun Aase, Hans Olav Fjaerli, Reidun Bull, Ingeborg Aaberge, Truls Michael Leegaard, and Britt Nakstad. 2016. “Etiology of Pneumonia in a Pediatric Population with High Pneumococcal Vaccine Coverage: A Prospective Study.” The Pediatric Infectious Disease Journal 35 (3): e69–75. https://doi.org/10.1097/INF.0000000000001009.

Bergenfelz, Caroline, and Anders P Hakansson. 2017. “Streptococcus pneumoniae Otitis Media Pathogenesis and How It Informs Our Understanding of Vaccine Strategies.” Current Otorhinolaryngology Reports 5 (2): 115–24. https://doi.org/10.1007/s40136-017-0152-6.

Berglund, Anders, Mats Ekelund, Mark A. Fletcher, and Lars Nyman. 2014. “All-cause pneumonia hospitalizations in children <2 years old in sweden, 1998 to 2012: impact of pneumococcal conjugate vaccine introduction.” Edited by Bernard Beall. PloS One 9 (11): e112211. https://doi.org/10.1371/journal.pone.0112211.

Bernal, James Lopez, Steven Cummins, and Antonio Gasparrini. 2016. “Interrupted time series regression for the evaluation of public health interventions: a tutorial.” International Journal of Epidemiology, 1–8. https://doi.org/10.1093/ije/dyw098.

Beutels, Philippe, Nancy Thiry, and Pierre Van Damme. 2007. “Convincing or confusing? Economic evaluations of childhood pneumococcal conjugate vaccination–a review (2002-2006).” Vaccine 25 (8): 1355–67. https://doi.org/10.1016/j.vaccine.2006.10.034.

Beutels, P., Z. Shkedy, M. Aerts, and P. Van Damme. 2006. “Social mixing patterns for transmission models of close contact infections: exploring self-evaluation and diary-based data collection through a web-based interface.” Epidemiology and Infection 134 (06): 1158. https://doi.org/10.1017/S0950268806006418.

Birnbaum, Howard G, Melissa Morley, Paul E Greenberg, M Cifaldi, and G L Colice. 2002. “Economic burden of pneumonia in an employed population.” Archives of Internal Medicine 161 (2): 2725–31. https://doi.org/10.1001/archinte.161.22.2725.

Bjarnason, Agnar, Hilmir Asgeirsson, Olafur Baldursson, Karl G Kristinsson, and Magnus Gottfredsson. 2015. “Mortality in healthcare-associated pneumonia in a low resistance setting: a prospective observational study.” Infectious Diseases (London, England) 47 (3): 130–36. https://doi.org/10.3109/00365548.2014.980842.

Bjarnason, Agnar, Johan Westin, Magnus Lindh, Lars-Magnus Andersson, Karl G. Kristinsson, Arthur Löve, Olafur Baldursson, and Magnus Gottfredsson. 2018. “Incidence, Etiology, and Outcomes of Community-Acquired Pneumonia: A Population-Based Study.” Open Forum Infectious Diseases 5 (2). https://doi.org/10.1093/ofid/ofy010.

Bjarnason, Skúli, Ingþór Friðriksson, and Jón Benediktsson. 1991. “Tíðni bráðrar miðeyrabólgu hjá börnum á svæði heilsugæslustöðvarinnar Borgarnesi.” Læknablaðið 77 (4): 137–40. http://www.hirsla.lsh.is/lsh/bitstream/2336/90415/1/L1991-04-77-F3.pdf.

Black, Nick. 1984. “Surgery for glue ear—A modern epidemic.” The Lancet 323 (8381): 835–37. https://doi.org/10.1016/S0140-6736(84)92280-3.

Black, S, H Shinefield, Bruce Fireman, E Lewis, P Ray, J R Hansen, L Elvin, et al. 2000. “Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group.” The Pediatric Infectious Disease Journal 19 (3): 187–95. http://www.ncbi.nlm.nih.gov/pubmed/10749457.

Black, Steven B, and H Shinefield. 2002. “Safety and efficacy of the seven-valent pneumococcal conjugate vaccine: evidence from Northern California.” Eur J Pediatr 161 Suppl: S127–31. https://doi.org/10.1007/s00431-002-1064-z.

Black, Steven B, H R Shinefield, S Ling, J Hansen, Bruce Fireman, D Spring, J Noyes, et al. 2002. “Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia.” Pediatr Infect Dis J 21 (9): 810–15. https://doi.org/10.1097/01.inf.0000027926.99356.4c.

Blank, Patricia R., and Thomas D. Szucs. 2012. “Cost-effectiveness of 13-valent pneumococcal conjugate vaccine in Switzerland.” Vaccine 30 (28): 4267–75. https://doi.org/10.1016/j.vaccine.2012.04.028.

Blank, Sarah J, David J Grindler, Kristine A Schulz, David L Witsell, and Judith E C Lieu. 2014. “Caregiver Quality of Life Is Related to Severity of Otitis Media in Children.” Otolaryngology-Head and Neck Surgery 151 (2): 348–53. https://doi.org/10.1177/0194599814531912.

Block, Stan L., James Hedrick, Christopher J. Harrison, Ron Tyler, Alan Smith, Rebecca Findlay, and Eileen Keegan. 2004. “Community-Wide Vaccination with the Heptavalent Pneumococcal Conjugate Significantly Alters the Microbiology of Acute Otitis Media.” The Pediatric Infectious Disease Journal 23 (9): 829–33. https://doi.org/10.1097/01.inf.0000136868.91756.80.

Blommaert, A, C Marais, N Hens, S Coenen, A Muller, H Goossens, and P Beutels. 2014. “Determinants of between-country differences in ambulatory antibiotic use and antibiotic resistance in Europe: a longitudinal observational study.” The Journal of Antimicrobial Chemotherapy 69 (2): 535–47. https://doi.org/10.1093/jac/dkt377.

Bluestone, C D, J S Stephenson, and L M Martin. 1992. “Ten-year review of otitis media pathogens.” The Pediatric Infectious Disease Journal 11 (8 Suppl): S7–11. https://doi.org/10.1097/00006454-199208001-00002.

Bright, R A, R M Moore, L L Jeng, C M Sharkness, S E Hamburger, and P M Hamilton. 1993. “The prevalence of tympanostomy tubes in children in the United States, 1988.” American Journal of Public Health 83 (7): 1026–8. http://www.ncbi.nlm.nih.gov/pubmed/8328599 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC1694786.

Browning, George G, Maroeska M Rovers, Ian Williamson, Jørgen Lous, and Martin J Burton. 2010. “Grommets (ventilation tubes) for hearing loss associated with otitis media with effusion in children.” Cochrane Database of Systematic Reviews, no. 10 (October). https://doi.org/10.1002/14651858.CD001801.pub3.

Bruhn, Christian A W, Stephen Hetterich, Cynthia Schuck-Paim, Esra Kürüm, Robert J Taylor, Roger Lustig, Eugene D Shapiro, Joshua L Warren, Lone Simonsen, and Daniel M Weinberger. 2017. “Estimating the population-level impact of vaccines using synthetic controls.” Proceedings of the National Academy of Sciences 114 (7): 1524–9. https://doi.org/10.1073/pnas.1612833114.

Bruyndonckx, R., N. Hens, M. Aerts, H. Goossens, J. Cortinas Abrahantes, and S. Coenen. 2015. “Exploring the association between resistance and outpatient antibiotic use expressed as DDDs or packages.” Journal of Antimicrobial Chemotherapy 70 (4): 1241–4. https://doi.org/10.1093/jac/dku525.

By, Åsa, Patrik Sobocki, Arne Forsgren, and Sven-Arne Silfverdal. 2012. “Comparing Health Outcomes and Costs of General Vaccination with Pneumococcal Conjugate Vaccines in Sweden: A Markov Model.” Clinical Therapeutics 34 (1): 177–89. https://doi.org/10.1016/j.clinthera.2011.12.007.

Byford, S, and J Raftery. 1998. “Economics notes: Perspectives in economic evaluation.” BMJ 316 (7143): 1529–30. https://doi.org/10.1136/bmj.316.7143.1529.

Casey, Janet R, Diana G Adlowitz, and Michael E Pichichero. 2009. “New Patterns in the Otopathogens Causing Acute Otitis Media Six to Eight Years After Introduction of Pneumococcal Conjugate Vaccine.” The Pediatric Infectious Disease Journal 29 (November): 1. https://doi.org/10.1097/INF.0b013e3181c1bc48.

Casey, Janet R., and Michael E. Pichichero. 2004. “Changes in frequency and pathogens causing acute otitis media in 1995-2003.” The Pediatric Infectious Disease Journal 23 (9): 824–8. https://doi.org/10.1097/01.inf.0000136871.51792.19.

Castiglia, Paolo, Lorenzo Pradelli, Stefano Castagna, Veronica Freguglia, Giorgio Palù, and Susanna Esposito. 2017. “Overall effectiveness of pneumococcal conjugate vaccines: An economic analysis of PHiD-CV and PCV-13 in the immunization of infants in Italy.” Human Vaccines & Immunotherapeutics 13 (10): 2307–15. https://doi.org/10.1080/21645515.2017.1343773.

Cecil, R. L. 1918. “Results of prophylactic inoculation against pneumococcus in 12,519 men.” Journal of Experimental Medicine 28 (1): 19–41. https://doi.org/10.1084/jem.28.1.19.

Chandran, Aruna, Hadley Herbert, Derek Misurski, and Mathuram Santosham. 2011. “Long-term sequelae of childhood bacterial meningitis: an underappreciated problem.” The Pediatric Infectious Disease Journal 30 (1): 3–6. https://doi.org/10.1097/INF.0b013e3181ef25f7.

Chen, Yi-Jen, Yu-Chia Hsieh, Yhu-Chering Huang, and Cheng-Hsun Chiu. 2013. “Clinical manifestations and microbiology of acute otitis media with spontaneous otorrhea in children.” Journal of Microbiology, Immunology and Infection 46 (5): 382–88. https://doi.org/10.1016/j.jmii.2013.04.001.

Cherian, T, EK Mulholland, JB Carlin, and H Ostensen. 2004. “Standardized Interpretation of Paediatric Chest Radiographs for the Diagnosis of Pneumonia in Epidemiological Studies Variability in the Interpretation of Chest Radiographs ! Standardized Method for Identifying Radiological Pneumonia Would Facilitate Read.” Bulletin of the World Health Organisation 83 (5): 353–59.

Chonmaitree, Tasnee, Rocio Trujillo, Kristofer Jennings, Pedro Alvarez-Fernandez, Janak A Patel, Michael J Loeffelholz, Johanna Nokso-Koivisto, et al. 2016. “Acute Otitis Media and Other Complications of Viral Respiratory Infection.” PEDIATRICS 137 (4): e20153555–e20153555. https://doi.org/10.1542/peds.2015-3555.

Chuck, Anderson W., Philip Jacobs, Gregory Tyrell, and James D. Kellner. 2010. “Pharmacoeconomic evaluation of 10- and 13-valent pneumococcal conjugate vaccines.” Vaccine 28: 5485–90. https://doi.org/10.1016/j.vaccine.2010.05.058.

Cilloniz, Catia, Ignacio Martin-Loeches, Carolina Garcia-Vidal, Alicia San Jose, and Antoni Torres. 2016. “Microbial etiology of pneumonia: Epidemiology, diagnosis and resistance patterns.” International Journal of Molecular Sciences 17 (12). https://doi.org/10.3390/ijms17122120.

Claesson, Bo A, Birger Trollfors, Inger Brolin, Marta Granström, J Henrichsen, Ulf Jodal, Per Juto, et al. 1989. “Etiology of community-acquired pneumonia in children based on antibody responses to bacterial and viral antigens.” The Pediatric Infectious Disease Journal 8 (12): 856–61. https://doi.org/10.1097/00006454-198912000-00006.

Claxton, Karl, Mike Paulden, Hugh Gravelle, Werner Brouwer, and Anthony J. Culyer. 2011. “Discounting and decision making in the economic evaluation of health-care technologies.” Health Economics 20 (1): 2–15. https://doi.org/10.1002/hec.1612.

Coker, Tumaini R, Linda S Chan, Sydne J Newberry, Mary Ann Limbos, Marika J Suttorp, Paul G Shekelle, and Glenn S Takata. 2010. “Diagnosis, Microbial Epidemiology, and Antibiotic Treatment of Acute Otitis Media in Children.” JAMA 304 (19): 2161. https://doi.org/10.1001/jama.2010.1651.

Cook, Richard J. (Richard John), and Jerald F. Lawless. 2007. The Statistical Analysis of Recurrent Events. Edited by M Gail, K Krickeberg, J Sarmet, A Tsiatis, and W Wong. New York: Springer Science + Business Media.

Costelloe, Céire, Chris Metcalfe, Andrew Lovering, David Mant, and Alastair D Hay. 2010. “Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis.” BMJ 340. http://www.bmj.com/content/340/bmj.c2096.long.

Coyte, P C, Ruth Croxford, C V Asche, T To, W Feldman, and J Friedberg. 2001. “Physician and population determinants of rates of middle-ear surgery in Ontario.” JAMA 286 (17): 2128–35. https://doi.org/10.1001/jama.286.17.2128.

Cullen, Karen A, Margaret J Hall, and Aleksandr Golosinskiy. 2009. “Ambulatory surgery in the United States, 2006.” National Health Statistics Reports, no. 11 (January): 1–25. http://www.ncbi.nlm.nih.gov/pubmed/19294964.

Culyer, Anthony J., and Kalipso Chalkidou. 2019. “Economic Evaluation for Health Investments En Route to Universal Health Coverage: Cost-Benefit Analysis or Cost-Effectiveness Analysis?” Value in Health 22 (1): 99–103. https://doi.org/10.1016/j.jval.2018.06.005.

Cutts, Felicity T, S M Zaman, Godwin C Enwere, S Jaffar, O S Levine, J B Okoko, C Oluwalana, et al. 2005. “Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial.” Lancet 365 (9465): 1139–46. https://doi.org/10.1016/s0140-6736(05)71876-6.

Dagan, Ron, M Sikuler-Cohen, O Zamir, J Janco, Noga Givon-Lavi, and D Fraser. 2001. “Effect of a conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use in day-care center attendees.” Pediatr Infect Dis J 20 (10): 951–58. http://www.ncbi.nlm.nih.gov/pubmed/11642629.

Danzon, Patricia M., Michael F. Drummond, Adrian Towse, and Mark V. Pauly. 2018. “Objectives, Budgets, Thresholds, and Opportunity Costs—A Health Economics Approach: An ISPOR Special Task Force Report [4].” Value in Health 21 (2): 140–45. https://doi.org/10.1016/j.jval.2017.12.008.

Davies, John A. V. 1937. “The Response of Infants to Inoculation with Type I Pneumococcus Carbohydrate.” The Journal of Immunology.

Davis, Stephanie M., Maria Deloria-Knoll, Hilina T. Kassa, and Katherine L. O’Brien. 2013. “Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: Review of evidence on indirect effects.” Vaccine 32 (1): 133–45. https://doi.org/10.1016/j.vaccine.2013.05.005.

Deibel, RH, and HW Seeley. 1974. “Family II: Streptococcuceae.” In Bergey’s Manual of Determinative Bacteriology, edited by R. E. Buchanan and N. E. Gibbons, 8th ed., 490–517. Baltimore: The William; Wilkins Co.

Delgleize, Emmanuelle, Oscar Leeuwenkamp, Eleni Theodorou, and Nicolas Van de Velde. 2016. “Cost-effectiveness analysis of routine pneumococcal vaccination in the UK: a comparison of the PHiD-CV vaccine and the PCV-13 vaccine using a Markov model.” BMJ Open 6 (11): e010776. https://doi.org/10.1136/bmjopen-2015-010776.

Desai, Shalini N, James D Kellner, and Derek Drummond. 2002. “Population-based, age-specific myringotomy with tympanostomy tube insertion rates in Calgary, Canada.” The Pediatric Infectious Disease Journal 21 (4): 348–50. http://www.ncbi.nlm.nih.gov/pubmed/12075770.

Devine, V. T., J. M. Jefferies, S. C. Clarke, and S. N. Faust. 2015. “Nasopharyngeal Bacterial Carriage in the Conjugate Vaccine Era with a Focus on Pneumococci.” Journal of Immunology Research 2015: 1–8. https://doi.org/10.1155/2015/394368.

De Wals, Philippe, Steven Black, Ray Borrow, and David Pearce. 2009. “Modeling the impact of a new vaccine on pneumococcal and nontypable Haemophilus influenzae diseases: A new simulation model.” Clinical Therapeutics 31 (10): 2152–69. https://doi.org/10.1016/j.clinthera.2009.10.014.

De Wals, Philippe, Elodie Robin, Elise Fortin, Roseline Thibeault, Manale Ouakki, and Monique Douville-Fradet. 2008. “Pneumonia After Implementation of the Pneumococcal Conjugate Vaccine Program in the Province of Quebec, Canada.” The Pediatric Infectious Disease Journal 27 (11): 963–68. https://doi.org/10.1097/INF.0b013e31817cf76f.

Díez-Domingo, Javier, Manuel Ridao-López, M Victoria Gutiérrez-Gimeno, Joan Puig-Barberá, Jose a Lluch-Rodrigo, and Eliseo Pastor-Villalba. 2011. “Pharmacoeconomic assessment of implementing a universal PCV-13 vaccination programme in the Valencian public health system (Spain).” Vaccine 29 (52): 9640–8. https://doi.org/10.1016/j.vaccine.2011.10.038.

Djurhuus, Bjarki Ditlev Ditlev, Axel Skytthe, Kaare Christensen, and Christian Emil Emil Faber. 2014. “Increasing rate of middle ear ventilation tube insertion in children in Denmark.” International Journal of Pediatric Otorhinolaryngology 78 (9): 1541–4. https://doi.org/10.1016/j.ijporl.2014.06.034.

Dochez, A Lz, and O T Avery. 1917. “The elaboration of specific soluble substance by pneumococcus during growth.” The Journal of Experimental Medicine. https://doi.org/10.1084/jem.26.4.477.

Dowling, John N, Paul R Sheehe, and Harry A Feldman. 1971. “Pharyngeal pneumococcal acquisitions in "normal" families: a longitudinal study.” The Journal of Infectious Diseases 124 (1): 9–17. http://www.ncbi.nlm.nih.gov/pubmed/4401272.

Drijkoningen, J J C, and G G U Rohde. 2014. “Pneumococcal infection in adults: burden of disease.” Clinical Microbiology and Infection : The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 20 Suppl 5 (May): 45–51. https://doi.org/10.1111/1469-0691.12461.

Durando, Paolo, Pietro Crovari, Filippo Ansaldi, Laura Sticchi, Camilla Sticchi, Valter Turello, Lorenzo Marensi, Raffaella Giacchino, Anna Timitilli, and Roberto Carloni. 2009. “Universal childhood immunisation against Streptococcus pneumoniae: The five-year experience of Liguria Region, Italy.” Vaccine 27 (25-26): 3459–62. https://doi.org/10.1016/j.vaccine.2009.01.052.

Dvorzak, Michaela, and Helga Wagner. 2019. Pogit: Bayesian Variable Selection for a Poisson-Logistic Model. https://CRAN.R-project.org/package=pogit.

Earnshaw, Stephanie R, Cheryl L McDade, Giovanni Zanotti, Raymond A Farkouh, and David Strutton. 2012. “Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada.” BMC Infectious Diseases 12 (1): 101. https://doi.org/10.1186/1471-2334-12-101.

Ekwurzel, G M, J S Simmons, L I Dublin, and L D Felton. 1938. “Studies on immunizing substances in pneumococci. VIII. Report on field tests to determine the prophylactic value of a pneumococcus antigen.” Public Health Rep 53 (42): 1877–93.

Elemraid, Mohamed A., Andrew D. Sails, Gary J. A. Eltringham, John D. Perry, Stephen P. Rushton, David A. Spencer, Matthew F. Thomas, et al. 2013. “Aetiology of paediatric pneumonia after the introduction of pneumococcal conjugate vaccine.” European Respiratory Journal 42 (6): 1595–1603. https://doi.org/10.1183/09031936.00199112.

“Enrolment in childcare and pre-schools.” 2013. Organisation for economic co-operation; development. http://www.oecd.org/social/soc/oecdfamilydatabase.htm.

Eskola, J, T. Kilpi, A. Palmu, J. Jokinen, J. Haapakoski, E. Herva, A. Takala, et al. 2001. “Efficacy of a pneumococcal conjugate vaccine against acute otitis media.” N Engl J Med 344 (6): 403–9. https://doi.org/10.1056/nejm200102083440602.

Esposito, Susanna, Alessandro Lizioli, Annalisa Lastrico, Enrica Begliatti, Alessandro Rognoni, Claudia Tagliabue, Laura Cesati, Vittorio Carreri, and Nicola Principi. 2007. “Impact on respiratory tract infections of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months of age.” Respiratory Research 8 (January): 12. https://doi.org/10.1186/1465-9921-8-12.

Eurostat. 2018. “Employment statistics.” https://ec.europa.eu/eurostat/statistics-explained/index.php/Employment{\_}statistics.

Falster, Kathleen, Deborah Randall, Emily Banks, Sandra Eades, Hasantha Gunasekera, Jennifer Reath, and Louisa Jorm. 2013. “Inequalities in ventilation tube insertion procedures between Aboriginal and non-Aboriginal children in New South Wales, Australia: a data linkage study.” BMJ Open 3 (11): e003807. https://doi.org/10.1136/bmjopen-2013-003807.

Feikin, Daniel R., Laura L. Hammitt, David R. Murdoch, Katherine L. O’Brien, and J. Anthony G. Scott. 2017. “The Enduring Challenge of Determining Pneumonia Etiology in Children: Considerations for Future Research Priorities.” Clinical Infectious Diseases 64 (suppl_3): S188–S196. https://doi.org/10.1093/cid/cix143.

Feikin, Daniel R, Anne Schuchat, Margarette Kolczak, Nancy L Barrett, Lee H Harrison, Lewis Lefkowitz, Allison McGeer, et al. 2000. “Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997.” American Journal of Public Health 90 (2): 223–29. https://doi.org/10.1097/00006454-200011000-00030.

Finland, M. 1931. “Specific cutaneous reactions and circulating antibodies in the course of lobar pneumonia.” Journal of Experimental Medicine 54 (5): 637–52. https://doi.org/10.1084/jem.54.5.637.

Finnbogadóttir, Anna Freyja, Hannes Petersen, Þröstur Laxdal, Fridrik Gudbrandsson, Þórólfur Gudnason, and Ásgeir Haraldsson. 2009. “An increasing incidence of mastoiditis in children in Iceland.” Scandinavian Journal of Infectious Diseases 41 (2): 95–98. https://doi.org/10.1080/00365540802593461.

Fireman, Bruce, Steven B Black, Henry R Shinefield, Janelle Lee, Edwin Lewis, and Paula Ray. 2003. “Impact of the pneumococcal conjugate vaccine on otitis media.” 1. 2003/01/25. Vol. 22. The Pediatric infectious disease journal. https://doi.org/10.1097/00006454-200301000-00006.

Florentzson, Rut, and Caterina Finizia. 2012. “Transmyringeal ventilation tube treatment: a 10-year cohort study.” International Journal of Pediatric Otorhinolaryngology 76 (8): 1117–22. https://doi.org/10.1016/j.ijporl.2012.04.013.

Fortanier, Alexandre C, Roderick P Venekamp, Marieke L A de Hoog, Cuno S P M Uiterwaal, Anne C van der Gugten, Cornelis K van der Ent, Arno W Hoes, and Anne G M Schilder. 2015. “Parent-Reported Symptoms of Acute Otitis Media during the First Year of Life: What Is beneath the Surface?” Edited by Herminia de Lencastre. PLOS ONE 10 (4): e0121572. https://doi.org/10.1371/journal.pone.0121572.

Francis, T, and W S Tillett. 1930. “Cutaneous reactions in pneumonia. The development of antibodies following the intradermal injection of type-specific polysaccharide.” The Journal of Experimental Medicine. https://doi.org/10.1084/jem.52.4.573.

Gefenaite, G, M J Bijlsma, H J Bos, and E Hak. 2014. “Did introduction of pneumococcal vaccines in the Netherlands decrease the need for respiratory antibiotics in children ? Analysis of 2002 to 2013 data.” Eurosurveillance 19 (44): 20948. https://doi.org/10.2807/1560-7917.ES2014.19.44.20948.

Gendrel, D., J. Raymond, F. Moulin, J. L. Iniguez, S. Ravilly, F. Habib, P. Lebon, and G. Kalifa. 1997. “Etiology and response to antibiotic therapy of community-acquired pneumonia in French children.” European Journal of Clinical Microbiology & Infectious Diseases 16 (5): 388–91. https://doi.org/10.1007/BF01726370.

Geno, K. Aaron, Gwendolyn L. Gilbert, Joon Young Song, Ian C. Skovsted, Keith P. Klugman, Christopher Jones, Helle B. Konradsen, and Moon H. Nahm. 2015. “Pneumococcal Capsules and Their Types: Past, Present, and Future.” Clinical Microbiology Reviews 28 (3): 871–99. https://doi.org/10.1128/CMR.00024-15.

Gilani, Zunera, Yuenting D. Kwong, Orin S. Levine, Maria Deloria-Knoll, J. Anthony G Scott, Katherine L. O’Brien, and Daniel R. Feikin. 2012. “A Literature Review and Survey of Childhood Pneumonia Etiology Studies: 2000–2010.” Clinical Infectious Diseases 54 (suppl_2): S102–S108. https://doi.org/10.1093/cid/cir1053.

Gisselsson-Solen, Marie. 2017. “Trends in Otitis Media Incidence After Conjugate Pneumococcal Vaccination; A National Observational Study.” The Pediatric Infectious Disease Journal 36 (11): 1. https://doi.org/10.1097/INF.0000000000001654.

Glezen, W. Paul, and Floyd W. Denny. 1973. “Epidemiology of Acute Lower Respiratory Disease in Children.” New England Journal of Medicine 288 (10): 498–505. https://doi.org/10.1056/NEJM197303082881005.

Goossens, Herman, Matus Ferech, Robert Vander Stichele, Monique Elseviers, and ESAC Project Group. 2005. “Outpatient antibiotic use in Europe and association with resistance: a cross-national database study.” Lancet (London, England) 365 (9459): 579–87. https://doi.org/10.1016/S0140-6736(05)17907-0.

Gouveia, Miguel, Francesca Fiorentino, Gonçalo Jesus, João Costa, and Margarida Borges. 2017. “Cost-effectiveness of the 13-valent Pneumococcal Conjugate Vaccine in Children in Portugal.” The Pediatric Infectious Disease Journal 36 (8): 782–87. https://doi.org/10.1097/INF.0000000000001587.

Gram, Christian. 1884. “Ueber die isolierte Fabung der Schizomyceten in Schnitt und Trockenpraparaten.” Fortschritte Der Medicin 2: 185–89.

Gray, Alastair M, Philip M Clarke, Jane L Wolstenholme, and Sarah Wordsworth. 2011. Applied Methods of Cost-effectiveness Analysis in Health Care. New York: Oxford University Press.

Greenberg, David, Natasha Bilenko, Zvika Liss, Tomer Shagan, Orly Zamir, and Ron Dagan. 2003. “The burden of acute otitis media on the patient and the family.” European Journal of Pediatrics 162 (9): 576–81. https://doi.org/10.1007/s00431-003-1260-5.

Gribben, Barry, Lesley J Salkeld, Simon Hoare, and Hannah F Jones. 2012. “The incidence of acute otitis media in New Zealand children under five years of age in the primary care setting.” Journal of Primary Health Care 4 (3): 205–12. http://www.ncbi.nlm.nih.gov/pubmed/22946068.

Griffin, Marie R., Yuwei Zhu, Matthew R. Moore, Cynthia G. Whitney, and Carlos G. Grijalva. 2013. “U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination.” The New England Journal of Medicine 369 (2): 155–63. https://doi.org/10.1056/NEJMoa1209165.

Grijalva, Carlos G., J. Pekka Nuorti, Patrick G. Arbogast, Stacey W. Martin, Kathryn M. Edwards, and Marie R. Griffin. 2007. “Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis.” Lancet 369 (9568): 1179–86. https://doi.org/10.1016/S0140-6736(07)60564-9.

Grijalva, Carlos G, J Pekka Nuorti, and Marie R Griffin. 2009. “Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings.” JAMA : The Journal of the American Medical Association 302 (7): 758–66. https://doi.org/10.1001/jama.2009.1163.

Grijalva, C. G., K. A. Poehling, J. P. Nuorti, Y. Zhu, S. W. Martin, K. M. Edwards, and M. R. Griffin. 2006. “National Impact of Universal Childhood Immunization With Pneumococcal Conjugate Vaccine on Outpatient Medical Care Visits in the United States.” PEDIATRICS 118 (3): 865–73. https://doi.org/10.1542/peds.2006-0492.

Groth, Anita, Frida Enoksson, Ann Hermansson, Malou Hultcrantz, Joacim Stalfors, and Karin Stenfeldt. 2011. “Acute mastoiditis in children in Sweden 1993-2007-No increase after new guidelines.” International Journal of Pediatric Otorhinolaryngology 75 (12): 1496–1501. https://doi.org/10.1016/j.ijporl.2011.08.015.

Groth, Christina, Reimar W Thomsen, and Therese Ovesen. 2015. “Association of pneumococcal conjugate vaccination with rates of ventilation tube insertion in Denmark: population-based register study.” BMJ Open 5 (6): e007151. https://doi.org/10.1136/bmjopen-2014-007151.

Gudnason, Thorolfur, Birgir Hrafnkelsson, Brynja Laxdal, and Karl G. Kristinsson. 2012. “Can risk factors for infectious illnesses in children at day care centres be identified?” Scand J Infect Dis 44 (2): 149–56. https://doi.org/10.3109/00365548.2011.599331.

Haapkylä, Johanna, Gunnhild Karevold, Kari Jorunn Kværner, and Anne Pitkäranta. 2008. “Trends in otitis media surgery: A decrease in adenoidectomy.” International Journal of Pediatric Otorhinolaryngology 72 (8): 1207–13. https://doi.org/10.1016/j.ijporl.2008.04.012.

Habib, Maha, Barbara D. Porter, and Catherine Satzke. 2014. “Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction.” Journal of Visualized Experiments, no. 84 (February). https://doi.org/10.3791/51208.

Hadley, Jack. 2003. “Sicker and Poorer—The Consequences of Being Uninsured: A Review of the Research on the Relationship between Health Insurance, Medical Care Use, Health, Work, and Income.” Medical Care Research and Review 60 (2_suppl): 3S–75S. https://doi.org/10.1177/1077558703254101.

Halloran, M. Elizabeth, Ira M. Longini, and Claudio J. Struchiner. 2010. Design and Analysis of Vaccine Studies. Statistics for Biology and Health. New York, NY: Springer New York. https://doi.org/10.1007/978-0-387-68636-3.

Hansen, John, Steven Black, Henry Shinefield, Thomas Cherian, Jane Benson, Bruce Fireman, Edwin Lewis, Paula Ray, and Janelle Lee. 2006. “Effectiveness of Heptavalent Pneumococcal Conjugate Vaccine in Children Younger Than 5 Years of Age for Prevention of Pneumonia.” The Pediatric Infectious Disease Journal 25 (9): 779–81. https://doi.org/10.1097/01.inf.0000232706.35674.2f.

Harboe, Zitta B, Reimar W Thomsen, Anders Riis, Palle Valentiner-Branth, Jens Jørgen Christensen, Lotte Lambertsen, Karen A Krogfelt, Helle B Konradsen, and Thomas Benfield. 2009. “Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study.” PLoS Medicine 6 (5): e1000081. https://doi.org/10.1371/journal.pmed.1000081.

Harboe, Zitta B, Palle Valentiner-Branth, Thomas Benfield, Jens Jørgen Christensen, Peter H Andersen, Michael Howitz, Karen A Krogfelt, Lotte Lambertsen, and Helle B Konradsen. 2010. “Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme.” Vaccine 28 (14): 2642–7. https://doi.org/10.1016/j.vaccine.2010.01.017.

Harrell, Jr., Frank E. 2019. Rms: Regression Modeling Strategies. https://CRAN.R-project.org/package=rms.

Heidelberger, M, and O T Avery. 1923. “THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS.” The Journal of Experimental Medicine. https://doi.org/10.1084/jem.40.3.301.

Heikkinen, T, and T Chonmaitree. 2003. “Importance of respiratory viruses in acute otitis media.” Clin Microbiol Rev 16 (2): 230–41.

Herdman, Michael, Amanda Cole, Christopher K Hoyle, Victoria Coles, Stuart Carroll, and Nancy Devlin. 2016. “Sources and Characteristics of Utility Weights for Economic Evaluation of Pediatric Vaccines: A Systematic Review.” Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research 19 (2): 255–66. https://doi.org/10.1016/j.jval.2015.11.003.

Hoek, Albert Jan van, Nick Andrews, Pauline a. Waight, Robert George, and Elizabeth Miller. 2012. “Effect of serotype on focus and mortality of invasive pneumococcal disease: Coverage of different vaccines and insight into non-vaccine serotypes.” PLoS ONE 7 (7). https://doi.org/10.1371/journal.pone.0039150.

Hoek, Albert Jan van, Yoon Hong Choi, Caroline Trotter, Elizabeth Miller, and Mark Jit. 2012. “The cost-effectiveness of a 13-valent pneumococcal conjugate vaccination for infants in England.” Vaccine 30 (50): 7205–13. https://doi.org/10.1016/j.vaccine.2012.10.017.

Holubar, Marisa, Maria Christina Stavroulakis, Yvonne Maldonado, John P A Ioannidis, and Despina Contopoulos-Ioannidis. 2017. “Impact of vaccine herd-protection effects in cost-effectiveness analyses of childhood vaccinations. A quantitative comparative analysis.” PLoS ONE 12 (3): 1–22. https://doi.org/10.1371/journal.pone.0172414.

Hoog, Marieke La a de, Roderick P Venekamp, Cornelis K van der Ent, Anne Schilder, Elisabeth Am M Sanders, Roger Amj M J Damoiseaux, Debby Bogaert, Cuno Spm P M Uiterwaal, Henriette a Smit, and Patricia Bruijning-Verhagen. 2014. “Impact of early daycare on healthcare resource use related to upper respiratory tract infections during childhood: prospective WHISTLER cohort study.” BMC Medicine 12 (1): 107. https://doi.org/10.1186/1741-7015-12-107.

Hoshino, Kazuhiko, Hiroshi Watanabe, Rinya Sugita, Norichika Asoh, Simon Angelo Ntabaguzi, Kiwao Watanabe, Kazunori Oishi, and Tsuyoshi Nagatake. 2002. “High rate of transmission of penicillin-resistant Streptococcus pneumoniae between parents and children.” Journal of Clinical Microbiology 40 (11): 4357–9. https://doi.org/10.1128/JCM.40.11.4357.

Howitz, Michael Frantz, Zitta Barrella Harboe, Helene Ingels, Palle Valentiner-Branth, Kåre Mølbak, and Bjarki Ditlev Djurhuus. 2017. “A nationwide study on the impact of pneumococcal conjugate vaccination on antibiotic use and ventilation tube insertion in Denmark 2000-2014.” Vaccine 35 (43): 5858–63. https://doi.org/10.1016/j.vaccine.2017.09.006.

Hsu, Heather E, Kathleen A Shutt, Matthew R Moore, Bernard W Beall, Nancy M Bennett, Allen S Craig, Monica M Farley, et al. 2009. “Effect of pneumococcal conjugate vaccine on pneumococcal meningitis.” The New England Journal of Medicine 360 (3): 244–56. https://doi.org/10.1056/NEJMoa0800836.

Hussain, M., A. Melegaro, R. G. Pebody, R. George, W. J. Edmunds, R. Talakudr, S. A. Martin, A. Efstratiou, and E. Miller. 2005. “A longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK setting.” Epidemiology and Infection 133 (05): 891. https://doi.org/10.1017/S0950268805004012.

Isaacman, Daniel J, David R Strutton, Edward a Kalpas, Nathalie Horowicz-Mehler, Lee S Stern, Roman Casciano, and Vincent Ciuryla. 2008. “The impact of indirect (herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine.” Clinical Therapeutics 30 (2): 341–57. https://doi.org/10.1016/j.clinthera.2008.02.003.

Jain, Seema, Derek J. Williams, Sandra R. Arnold, Krow Ampofo, Anna M. Bramley, Carrie Reed, Chris Stockmann, et al. 2015. “Community-Acquired Pneumonia Requiring Hospitalization among U.S. Children.” New England Journal of Medicine 372 (9): 835–45. https://doi.org/10.1056/NEJMoa1405870.

Jandoc, Racquel, Andrea M. Burden, Muhammad Mamdani, Linda E. Lévesque, and Suzanne M. Cadarette. 2015. “Interrupted time series analysis in drug utilization research is increasing: Systematic review and recommendations.” In Journal of Clinical Epidemiology, 68:950–56. 8. https://doi.org/10.1016/j.jclinepi.2014.12.018.

Jardine, Andrew, Robert I. Menzies, Shelley L. Deeks, Mahomed S. Patel, and Peter B. McIntyre. 2009. “The impact of pneumococcal conjugate vaccine on rates of myringotomy with ventilation tube insertion in Australia.” The Pediatric Infectious Disease Journal 28 (9): 761–5. https://doi.org/10.1097/INF.0b013e31819e9bc5.

Jardine, Andrew, Robert I. Menzies, and Peter B. McIntyre. 2010. “Reduction in Hospitalizations for Pneumonia Associated With the Introduction of a Pneumococcal Conjugate Vaccination Schedule Without a Booster Dose in Australia.” The Pediatric Infectious Disease Journal 29 (7): 607–12. https://doi.org/10.1097/INF.0b013e3181d7d09c.

Kastenbauer, S., and H.-W. Pfister. 2003. “Pneumococcal meningitis in adults: Spectrum of complications and prognostic factors in a series of 87 cases.” Brain 126 (5): 1015–25. https://doi.org/10.1093/brain/awg113.

Kaur, Ravinder, Matthew Morris, and Michael E. Pichichero. 2017. “Epidemiology of Acute Otitis Media in the Postpneumococcal Conjugate Vaccine Era.” Pediatrics 140 (3): e20170181. https://doi.org/10.1542/peds.2017-0181.

Keitel, K, G Alcoba, L Lacroix, S Manzano, a Galetto-Lacour, and a Gervaix. 2014. “Observed costs and health care use of children in a prospective cohort study on community-acquired pneumonia in Geneva, Switzerland.” Swiss Medical Weekly 144 (April): w13925. https://doi.org/10.4414/smw.2014.13925.

Keyhani, Salomeh, Lawrence C Kleinman, Michael Rothschild, Joseph M Bernstein, Rebecca Anderson, and Mark Chassin. 2008. “Overuse of tympanostomy tubes in New York metropolitan area: evidence from five hospital cohort.” BMJ (Clinical Research Ed.) 337 (5): a1607. https://doi.org/10.1136/bmj.a1607.

Kilpi, T, Heidi Ahman, J Jokinen, K S Lankinen, A Palmu, H Savolainen, M Gronholm, et al. 2003. “Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate v.” Clin Infect Dis 37 (9): 1155–64. https://doi.org/10.1086/378744.

Kilpi, T. M., J. Jokinen, T. Puumalainen, H. Nieminen, E. Ruokokoski, H. Rinta-Kokko, M. Traskine, et al. 2018. “Effectiveness of pneumococcal Haemophilus influenzae protein D conjugate vaccine against pneumonia in children: A cluster-randomised trial.” Vaccine 36 (39): 5891–5901. https://doi.org/10.1016/j.vaccine.2018.08.020.

Kim, Su Jin, Ji Hyun Chung, Ho Min Kang, and Seung Geun Yeo. 2013. “Clinical bacteriology of recurrent otitis media with effusion.” Acta Oto-Laryngologica 133 (11): 1133–41. https://doi.org/10.3109/00016489.2013.816442.

Kim, Sun-young, and Sue J Goldie. 2008. “Cost-effectiveness analyses of vaccination programmes : a focused review of modelling approaches.” PharmacoEconomics 26 (3): 191–215. https://doi.org/2634 [pii].

Kirkwood, BR, and JAC Sterne. 2003. Essential medical statistics. Edited by Fiona Goodgame. 2nd ed. Oxford: Blackwell Science. https://doi.org/10.1002/sim.1961.

Klok, Rogier M, Rose-Marie Lindkvist, Mats Ekelund, Raymond a Farkouh, and David R Strutton. 2013. “Cost-Effectiveness of a 10- Versus 13-Valent Pneumococcal Conjugate Vaccine in Denmark and Sweden.” Clinical Therapeutics 35 (2): 119–34. https://doi.org/10.1016/j.clinthera.2012.12.006.

Knerer, Gerhart, Afisi Ismaila, and David Pearce. 2012. “Health and economic impact of PHiD-CV in Canada and the UK: a Markov modelling exercise.” Journal of Medical Economics 15 (1): 61–76. https://doi.org/10.3111/13696998.2011.622323.

Kogan, M D, M D Overpeck, H J Hoffman, and M L Casselbrant. 2000. “Factors associated with tympanostomy tube insertion among preschool-aged children in the United States.” American Journal of Public Health 90 (2): 245–50.

Kontopantelis, Evangelos, Tim Doran, David A Springate, Iain Buchan, and David Reeves. 2015. “Regression based quasi-experimental approach when randomisation is not an option: interrupted time series analysis.” BMJ (Clinical Research Ed.) 350 (January): h2750. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4460815{\&}tool=pmcentrez{\&}rendertype=abstract.

Koshy, E., J. Murray, A. Bottle, M. Sharland, and S. Saxena. 2010. “Impact of the seven-valent pneumococcal conjugate vaccination (PCV7) programme on childhood hospital admissions for bacterial pneumonia and empyema in England: national time-trends study, 1997-2008.” Thorax 65 (9): 770–74. https://doi.org/10.1136/thx.2010.137802.

Kuhlmann, Alexander, and J-Matthias Graf von der Schulenburg. 2017. “Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany.” The European Journal of Health Economics 18 (3): 273–92. https://doi.org/10.1007/s10198-016-0770-9.

Kvaerner, Kari J, Per Nafstad, and Jouni J K Jaakkola. 2002. “Otolaryngological surgery and upper respiratory tract infections in children: an epidemiological study.” The Annals of Otology, Rhinology, and Laryngology 111 (11): 1034–9. https://doi.org/10.1177/000348940211101115.

Ladhani, Shamez N., Mary P E Slack, Nick Andrews, Pauline a. Waight, Ray Borrow, and Elizabeth Miller. 2013. “Invasive pneumococcal disease after routine pneumococcal conjugate vaccination in children, England and Wales.” Emerging Infectious Diseases 19 (1): 61–68. https://doi.org/10.3201/eid1901.120741.

Lau, Wallis C Y, Macey Murray, Aisha El-Turki, Sonia Saxena, Shamez Ladhani, Paul Long, Mike Sharland, Ian C K Wong, and Yingfen Hsia. 2015. “Impact of pneumococcal conjugate vaccines on childhood otitis media in the United Kingdom.” Vaccine 33 (39): 5072–9. https://doi.org/10.1016/j.vaccine.2015.08.022.

Legood, Rosa, Pietro G Coen, Kyle Knox, Russell M Viner, Haitham El Bashir, Deborah Christie, Bharat C Patel, and Robert Booy. 2009. “Health related quality of life in survivors of pneumococcal meningitis.” Acta Paediatrica 98 (3): 543–47. https://doi.org/10.1111/j.1651-2227.2008.01136.x.

Leino, Tuija, Kari Auranen, Jukka Jokinen, Maija Leinonen, Päivi Tervonen, and Aino K. Takala. 2001. “Pneumococcal carriage in children during their first two years: important role of family exposure.” The Pediatric Infectious Disease Journal 20 (11): 1022–7. https://doi.org/10.1097/00006454-200111000-00004.

Le Polain de Waroux, Olivier, Stefan Flasche, David Prieto-Merino, and W John Edmunds. 2014. “Age-Dependent Prevalence of Nasopharyngeal Carriage of Streptococcus pneumoniae before Conjugate Vaccine Introduction: A Prediction Model Based on a Meta-Analysis.” Edited by Hiroshi Nishiura. PLoS ONE 9 (1): e86136. https://doi.org/10.1371/journal.pone.0086136.

Levine, Orin S., Katherine L. O’Brien, Maria Deloria-Knoll, David R. Murdoch, Daniel R. Feikin, A. N. DeLuca, Amanda J. Driscoll, et al. 2012. “The Pneumonia Etiology Research for Child Health Project: A 21st Century Childhood Pneumonia Etiology Study.” Clinical Infectious Diseases 54 (suppl 2): S93–S101. https://doi.org/10.1093/cid/cir1052.

Liese, J. G., S. A. Silfverdal, C. Giaquinto, A. Carmona, J. H. Larcombe, J. Garcia-Sicilia, A. Fuat, et al. 2014. “Incidence and clinical presentation of acute otitis media in children aged <6 years in European medical practices.” Epidemiology and Infection 142 (8): 1778–88. https://doi.org/10.1017/S0950268813002744.

Lin, D. Y., and L. J. Wei. 1989. “The Robust Inference for the Cox Proportional Hazards Model.” Journal of the American Statistical Association 84 (408): 1074–8. https://doi.org/10.1080/01621459.1989.10478874.

Lister, Frederick Spencer. 1916. “An experimental study of prophylactic inoculation against pneumococcal infection in the rabbit and in man.” Publication of the South African Institute of Medical Research 8: 231–87.

Lister, Frederick Spencer, and D Ordman. 1936. “The Epidemiology of Pneumonia on the Witwatersrand Goldfields and the Prevention of Pneumonia and Other Allied Acute Respiratory Diseases in Native Labourers in South Africa by Means of Vaccine.” Journal of the American Medical Association 106 (9): 733. https://doi.org/10.1001/jama.1936.02770090069032.

Loo, Jennifer D., Laura Conklin, Katherine E. Fleming-Dutra, Maria Deloria Knoll, Daniel E. Park, Jennifer Kirk, David Goldblatt, et al. 2014. “Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on prevention of pneumonia.” The Pediatric Infectious Disease Journal 33 Suppl 2 (1): S140–51. https://doi.org/10.1097/INF.0000000000000082.

Loo, Jennifer D, Laura Conklin, Katherine E Fleming-Dutra, Maria Deloria Knoll, Daniel E Park, Jennifer Kirk, David Goldblatt, Katherine L O’Brien, and Cynthia G Whitney. 2014. “Systematic review of the indirect effect of pneumococcal conjugate vaccine dosing schedules on pneumococcal disease and colonization.” The Pediatric Infectious Disease Journal 33 Suppl 2 (1): S161–71. https://doi.org/10.1097/INF.0000000000000084.

Macintyre, EA, CJ Karr, M Koehoorn, P Demers, L Tamburic, C Lencar, and Michael Brauer. 2010. “Otitis media incidence and risk factors in a population-based birth cohort.” Paediatrics and Child Health 15 (7): 437–42.

Mackenzie, Grant. 2016. “The definition and classification of pneumonia.” Pneumonia 8 (1): 14. https://doi.org/10.1186/s41479-016-0012-z.

Macleod, C M, Richard G Hodges, Michael Heidelberger, and W G Bernhard. 1945. “PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES.” The Journal of Experimental Medicine 82 (6): 445–65. http://www.ncbi.nlm.nih.gov/pubmed/19871511 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC2135567.

Maddigan, Sheri L., David H. Feeny, and Jeffrey A. Johnson. 2005. “Health-related quality of life deficits associated with diabetes and comorbidities in a Canadian National Population Health Survey.” Quality of Life Research 14 (5): 1311–20. https://doi.org/10.1007/s11136-004-6640-4.

Madhi, Shabir a, Philippe De Wals, Carlos G Grijalva, Keith Grimwood, Ronald Grossman, Naruhiko Ishiwada, Ping-Ing Lee, et al. 2012. “The Burden of Childhood Pneumonia in the Developed World.” The Pediatric Infectious Disease Journal 32 (3): 1. https://doi.org/10.1097/INF.0b013e3182784b26.

Magnus, Maria C, Didrik F Vestrheim, Wenche Nystad, Siri Eldevik Håberg, Hein Stigum, Stephanie J London, Marianne R A R Bergsaker, Dominique A Caugant, Ingeborg S Aaberge, and Per Nafstad. 2012. “Decline in early childhood respiratory tract infections in the Norwegian mother and child cohort study after introduction of pneumococcal conjugate vaccination.” The Pediatric Infectious Disease Journal 31 (9): 951–5. https://doi.org/10.1097/INF.0b013e31825d2f76.

Mangen, Marie-Josée J, Susanne M. Huijts, Marc J M Bonten, and G. Ardine de Wit. 2017. “The impact of community-acquired pneumonia on the health-related quality-of-life in elderly.” BMC Infectious Diseases 17 (1): 208. https://doi.org/10.1186/s12879-017-2302-3.

Marchisio, Paola, Luigi Cantarutti, Miriam Sturkenboom, Silvia Girotto, Gino Picelli, Daniele Dona, Antonio Scamarcia, Marco Villa, Carlo Giaquinto, and Pedianet. 2012. “Burden of acute otitis media in primary care pediatrics in Italy: a secondary data analysis from the Pedianet database.” BMC Pediatrics 12 (1): 185. https://doi.org/10.1186/1471-2431-12-185.

Marom, Tal, Ofer Israel, Haim Gavriel, Jacob Pitaro, Ali Abo Baker, and Ephraim Eviatar. 2017. “Comparison of first year of life acute otitis media admissions before and after the 13-valent pneumococcal conjugate vaccine.” International Journal of Pediatric Otorhinolaryngology 97 (June): 251–56. https://doi.org/10.1016/j.ijporl.2017.04.023.

Marom, Tal, Alai Tan, Gregg S. Wilkinson, Karen S. Pierson, Jean L. Freeman, and Tasnee Chonmaitree. 2014. “Trends in otitis media-related health care use in the United States, 2001-2011.” JAMA Pediatrics 168 (1): 68–75. https://doi.org/10.1001/jamapediatrics.2013.3924.

Mauskopf, Josephine, Baudouin Standaert, Mark P. Connolly, Anthony J. Culyer, Louis P. Garrison, Raymond Hutubessy, Mark Jit, Richard Pitman, Paul Revill, and Johan L. Severens. 2018. “Economic Analysis of Vaccination Programs: An ISPOR Good Practices for Outcomes Research Task Force Report.” Value in Health 21 (10): 1133–49. https://doi.org/10.1016/j.jval.2018.08.005.

Maynard, G D. 1913. “An enquiry into the etiology, manifestations and prevention of pneumonia amongst natives on the Rand recruited from tropical areas.” Public South Afr Inst Med Res 1 (0): 1–101.

Mäkelä, P H, M Leinonen, J Pukander, and P Karma. 1981. “A study of the pneumococcal vaccine in prevention of clinically acute atttacks of recurrent otitis media.” Reviews of Infectious Diseases 3 Suppl: S124–32. http://www.ncbi.nlm.nih.gov/pubmed/6974386.

McLaughlin, John M, Eric A Utt, Nina M Hill, Verna L Welch, Edward Power, and Gregg C Sylvester. 2016. “A current and historical perspective on disparities in US childhood pneumococcal conjugate vaccine adherence and in rates of invasive pneumococcal disease: Considerations for the routinely-recommended, pediatric PCV dosing schedule in the United States.” Human Vaccines & Immunotherapeutics 12 (1): 206–12. https://doi.org/10.1080/21645515.2015.1069452.

Melegaro, A, and W. J. Edmunds. 2004. “Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales.” Vaccine 22 (31-32): 4203–14. https://doi.org/10.1016/j.vaccine.2004.05.003.

Melegaro, A., N. J. Gay, and G. F. Medley. 2004. “Estimating the transmission parameters of pneumococcal carriage in households.” Epidemiology and Infection 132 (3): 433–41. https://doi.org/10.1017/S0950268804001980.

Monasta, Lorenzo, Luca Ronfani, Federico Marchetti, Marcella Montico, Liza Vecchi Brumatti, Alessandro Bavcar, Domenico Grasso, et al. 2012. “Burden of disease caused by otitis media: Systematic review and global estimates.” PLoS ONE 7 (4): e36226. https://doi.org/10.1371/journal.pone.0036226.

Moore, Matthew R., Ruth Link-Gelles, William Schaffner, Ruth Lynfield, Catherine Lexau, Nancy M. Bennett, Susan Petit, et al. 2015. “Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: Analysis of multisite, population-based surveillance.” The Lancet Infectious Diseases 15 (3): 301–9. https://doi.org/10.1016/S1473-3099(14)71081-3.

Morrow, Adrienne, Philippe De Wals, Geneviève Petit, Maryse Guay, and Lonny James Erickson. 2007. “The Burden of Pneumococcal Disease in the Canadian Population Before Routine Use of the Seven-Valent Pneumococcal Conjugate Vaccine.” Canadian Journal of Infectious Diseases and Medical Microbiology 18 (2): 121–27. https://doi.org/10.1155/2007/713576.

Mosser, Jonathan F., Lindsay R. Grant, Eugene V. Millar, Robert C. Weatherholtz, Delois M. Jackson, Bernard Beall, Mariddie J. Craig, Raymond Reid, Mathuram Santosham, and Katherine L. O’Brien. 2014. “Nasopharyngeal carriage and transmission of Streptococcus pneumoniae in American Indian households after a decade of pneumococcal conjugate vaccine use.” PLoS ONE 9 (1): 3–10. https://doi.org/10.1371/journal.pone.0079578.

Mufson, M A, and R J Stanek. 1999. “Bacteremic pneumococcal pneumonia in one American City: a 20-year longitudinal study, 1978-1997.” The American Journal of Medicine 107 (1A): 34S–43S. http://www.ncbi.nlm.nih.gov/pubmed/10451007.

Myint, Tin Tin Htar, Harish Madhava, Paul Balmer, Dina Christopoulou, Sepideh Attal, Damianos Menegas, Ralf Sprenger, and Eric Bonnet. 2013. “The impact of 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease: a literature review.” Advances in Therapy 30 (2): 127–51. https://doi.org/10.1007/s12325-013-0007-6.

Nair, Harish, Arun Thor Watts, Linda J. Williams, Saad B. Omer, Colin R. Simpson, Lorna J. Willocks, J. Claire Cameron, and Harry Campbell. 2016. “Pneumonia hospitalisations in Scotland following the introduction of pneumococcal conjugate vaccination in young children.” BMC Infectious Diseases 16 (1): 390. https://doi.org/10.1186/s12879-016-1693-x.

Newall, Anthony T., Prudence Creighton, David J. Philp, James G. Wood, and C. Raina MacIntyre. 2011. “The potential cost-effectiveness of infant pneumococcal vaccines in Australia.” Vaccine 29: 8077–85. https://doi.org/10.1016/j.vaccine.2011.08.050.

Newall, A. T., J. F. Reyes, P. McIntyre, R. Menzies, P. Beutels, and J. G. Wood. 2016. “Retrospective economic evaluation of childhood 7-valent pneumococcal conjugate vaccination in Australia: Uncertain herd impact on pneumonia critical.” Vaccine 34 (3): 320–27. https://doi.org/10.1016/j.vaccine.2015.11.053.

Ngo, Chinh C., Helen M. Massa, Ruth B. Thornton, and Allan W. Cripps. 2016. “Predominant Bacteria Detected from the Middle Ear Fluid of Children Experiencing Otitis Media: A Systematic Review.” Edited by Sean Reid. PloS One 11 (3): e0150949. https://doi.org/10.1371/journal.pone.0150949.

Nicholls, Thomas Rodger, Amanda Jane Leach, and Peter Stanley Morris. 2016. “The short-term impact of each primary dose of pneumococcal conjugate vaccine on nasopharyngeal carriage: Systematic review and meta-analyses of randomised controlled trials.” Vaccine 34 (6): 703–13. https://doi.org/10.1016/j.vaccine.2015.12.048.

O’Brien, Katherine L., Angeline B David, Aruna Chandran, Lawrence H Moulton, Raymond Reid, Robert Weatherholtz, and Mathuram Santosham. 2008. “RANDOMIZED, CONTROLLED TRIAL EFFICACY OF PNEUMOCOCCAL CONJUGATE VACCINE AGAINST OTITIS MEDIA AMONG NAVAJO AND WHITE MOUNTAIN APACHE INFANTS.” The Pediatric Infectious Disease Journal 27 (1): 71–73. https://doi.org/10.1097/INF.0b013e318159228f.

O’Brien, Katherine L, Lawrence H Moulton, Raymond Reid, Robert Weatherholtz, Jane Oski, Laura Brown, Gaurav Kumar, et al. 2003. “Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial.” Lancet 362 (9381): 355–61. https://doi.org/10.1016/S0140-6736(03)14022-6.

O’Brien, Katherine L., Lara J. Wolfson, James P. Watt, Emily Henkle, Maria Deloria-Knoll, Natalie McCall, Ellen Lee, et al. 2009. “Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates.” The Lancet 374 (9693): 893–902. https://doi.org/10.1016/S0140-6736(09)61204-6.

O’Brien, Megan A, Lisa A Prosser, Jack L Paradise, G Thomas Ray, Martin Kulldorff, Marcia Kurs-Lasky, Virginia L Hinrichsen, Jyotsna Mehta, D Kathleen Colborn, and Tracy A Lieu. 2009. “New vaccines against otitis media: projected benefits and cost-effectiveness.” Pediatrics 123 (6): 1452–63. https://doi.org/10.1542/peds.2008-1482.

OECD. 2019. “Employment rate (indicator).” https://doi.org/10.1787/1de68a9b-en.

OECD Labour Force Statistics. 2018. OECD Labour Force Statistics. OECD. https://doi.org/10.1787/oecd_lfs-2018-en.

Oliveira, Lucia Helena de, Silas Pierson Trumbo, Cuauhtémoc Ruiz Matus, N. Jennifer Sanwogou, and Cristiana M. Toscano. 2016. “Pneumococcal conjugate vaccine introduction in Latin America and the Caribbean: progress and lessons learned.” Expert Review of Vaccines 15 (10): 1295–1304. https://doi.org/10.1586/14760584.2016.1166961.

Oostenbrink, Rianne, Henriëtte A Moll, and Marie-Louise Essink-Bot. 2002. “The EQ-5D and the Health Utilities Index for permanent sequelae after meningitis.” Journal of Clinical Epidemiology 55 (8): 791–99. https://doi.org/10.1016/S0895-4356(02)00448-1.

Paisley, John W., Brian A. Lauer, Kenneth Mcintosh, Mary P. Glode, Julius Schachter, and Acarol Rumack. 1984. “Pathogens associated with acute lower respiratory tract infection in young children.” The Pediatric Infectious Disease Journal 3 (1): 14–19. https://doi.org/10.1097/00006454-198401000-00005.

Palmu, Arto A, Jukka Jokinen, Dorota Borys, Heta Nieminen, Esa Ruokokoski, Lotta Siira, Taneli Puumalainen, et al. 2013. “Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial.” Lancet 381 (9862): 214–22. https://doi.org/10.1016/s0140-6736(12)61854-6.

Palmu, Arto A, Jukka Jokinen, Heta Nieminen, Hanna Rinta-Kokko, Esa Ruokokoski, Taneli Puumalainen, Dorota Borys, et al. 2014. “Effect of pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) on outpatient antimicrobial purchases: a double-blind, cluster randomised phase 3-4 trial.” The Lancet Infectious Diseases 14 (3): 205–12. https://doi.org/10.1016/S1473-3099(13)70338-4.

Palmu, Arto a, Terhi M Kilpi, Hanna Rinta-Kokko, Hanna Nohynek, Maija Toropainen, J Pekka Nuorti, and Jukka Jokinen. 2015. “Pneumococcal Conjugate Vaccine and Clinically Suspected Invasive Pneumococcal Disease.” Pediatrics 136 (1): e22 LP–e27. https://doi.org/10.1542/peds.2015-0458.

Palmu, Arto A, Hanna Rinta-Kokko, Hanna Nohynek, J Pekka Nuorti, and Jukka Jokinen. 2017. “Impact of National Ten-Valent Pneumococcal Conjugate Vaccine Programme on Reducing Antimicrobial Use and Tympanostomy Tube Placements in Finland.” The Pediatric Infectious Disease Journal 37 (1): 1. https://doi.org/10.1097/INF.0000000000001810.

Palmu, Arto, Jukka Jokinen, Heta Nieminen, Hanna Rinta-Kokko, Esa Ruokokoski, Taneli Puumalainen, Magali Traskine, et al. 2015. “Effectiveness of the 10-Valent Pneumococcal Conjugate Vaccine Against Tympanostomy Tube Placements in a Cluster-Randomized Trial.” The Pediatric Infectious Disease Journal 34 (11): 1230–5. https://doi.org/http://dx.doi.org/10.1097/INF.0000000000000857.

Paradise, Jack L., Heidi M. Feldman, Thomas F. Campbell, Christine A. Dollaghan, D. Kathleen Colborn, Beverly S. Bernard, Howard E. Rockette, et al. 2001. “Effect of Early or Delayed Insertion of Tympanostomy Tubes for Persistent Otitis Media on Developmental Outcomes at the Age of Three Years.” New England Journal of Medicine 344 (16): 1179–87. https://doi.org/10.1056/NEJM200104193441601.

Paradise, Jack L., Heidi M. Feldman, Thomas F. Campbell, Christine A. Dollaghan, Howard E. Rockette, Dayna L. Pitcairn, Clyde G. Smith, et al. 2007. “Tympanostomy Tubes and Developmental Outcomes at 9 to 11 Years of Age.” New England Journal of Medicine 356 (3): 248–61. https://doi.org/10.1056/NEJMoa062980.

Paradise, Jack L., Howard E. Rockette, D. Kathleen Colborn, Beverly S. Bernard, Clyde G. Smith, Marcia Kurs-Lasky, and Janine E. Janosky. 1997. “Otitis media in 2253 Pittsburgh-area infants: prevalence and risk factors during the first two years of life.” Pediatrics 99 (3): 318–33. http://pediatrics.aappublications.org/content/99/3/318.long{\#}T2 http://www.ncbi.nlm.nih.gov/pubmed/9041282.

Pasteur, Louis. 1881. “Note sur la maladie nouvelle provoquee par la salive d’un enfant mort de la rage.” 10. Vol. 2. Paris: I’Academie de Medicine. https://gallica.bnf.fr/ark:/12148/bpt6k408671n.

Pedersen, Tine Marie, Anna-Rosa Cecilie Mora-Jensen, Johannes Waage, Hans Bisgaard, and Jakob Stokholm. 2016. “Incidence and Determinants of Ventilation Tubes in Denmark.” PloS One 11 (11): e0165657. https://doi.org/10.1371/journal.pone.0165657.

Penfold, Robert B, and Fang Zhang. 2013. “Use of interrupted time series analysis in evaluating health care quality improvements.” Academic Pediatrics 13 (6 Suppl): S38–44. https://doi.org/10.1016/j.acap.2013.08.002.

Petrou, Stavros, and Emil Kupek. 2009. “Estimating preference-based health utilities index mark 3 utility scores for childhood conditions in England and Scotland.” Medical Decision Making : An International Journal of the Society for Medical Decision Making 29 (3): 291–303. https://doi.org/10.1177/0272989X08327398.

Pichichero, Michael E., Janet R. Casey, Alejandro Hoberman, and Richard Schwartz. 2008. “Pathogens causing recurrent and difficult-to-treat acute otitis media, 2003-2006.” Clinical Pediatrics 47 (9): 901–6. https://doi.org/10.1177/0009922808319966.

Pitman, Richard, David Fisman, Gregory S. Zaric, Maarten Postma, Mirjam Kretzschmar, John Edmunds, and Marc Brisson. 2012. “Dynamic Transmission Modeling.” Medical Decision Making 32 (5): 712–21. https://doi.org/10.1177/0272989X12454578.

Poehling, K. A. 2004. “Population-Based Impact of Pneumococcal Conjugate Vaccine in Young Children.” PEDIATRICS 114 (3): 755–61. https://doi.org/10.1542/peds.2003-0592-F.

Poehling, Katherine A, Peter G Szilagyi, Carlos G Grijalva, Stacey W Martin, Bonnie LaFleur, Ed Mitchel, Richard D Barth, J Pekka Nuorti, and Marie R Griffin. 2007. “Reduction of Frequent Otitis Media and Pressure-Equalizing Tube Insertions in Children After Introduction of Pneumococcal Conjugate Vaccine.” PEDIATRICS 119 (4): 707–15. https://doi.org/10.1542/peds.2006-2138.

Prieto, Luis, and José A. Sacristán. 2003. “Problems and solutions in calculating quality-adjusted life years (QALYs).” Health and Quality of Life Outcomes 1: 1–8. https://doi.org/10.1186/1477-7525-1-80.

Prosser, Lisa A, G Thomas Ray, M. O’Brien, Ken Kleinman, Jeanne Santoli, and Tracy A Lieu. 2004. “Preferences and Willingness to Pay for Health States Prevented by Pneumococcal Conjugate Vaccine.” PEDIATRICS 113 (2): 283–90. https://doi.org/10.1542/peds.113.2.283.

Prymula, Roman, Pascal Peeters, Viktor Chrobok, Pavla Kriz, Elena Novakova, Eva Kaliskova, Igor Kohl, et al. 2006. “Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: A randomised double-blind efficacy study.” Lancet 367 (9512): 740–48. https://doi.org/10.1016/S0140-6736(06)68304-9.

Pulido, Marifi, and Frank Sorvillo. 2010. “Declining invasive pneumococcal disease mortality in the United States, 1990-2005.” Vaccine 28 (4): 889–92. https://doi.org/10.1016/j.vaccine.2009.10.121.

Pumarola, Felix, Josep Marès, Isabel Losada, Isabel Minguella, Fernando Moraga, David Tarragó, Ulla Aguilera, et al. 2013. “Microbiology of bacteria causing recurrent acute otitis media (AOM) and AOM treatment failure in young children in Spain: Shifting pathogens in the post-pneumococcal conjugate vaccination era.” International Journal of Pediatric Otorhinolaryngology 77 (8): 1231–6. https://doi.org/10.1016/j.ijporl.2013.04.002.

Quirk, Sigríður J, Gunnsteinn Haraldsson, Helga Erlendsdóttir, Martha Á Hjálmarsdóttir, Andries J van Tonder, Birgir Hrafnkelsson, Samuel Sigurdsson, et al. 2018. “Effect of Vaccination on Pneumococci Isolated from the Nasopharynx of Healthy Children and the Middle Ear of Children with Otitis Media in Iceland.” Edited by Daniel J. Diekema. Journal of Clinical Microbiology 56 (12): 1–14. https://doi.org/10.1128/JCM.01046-18.

Ramakrishnan, Kalyanakrishnan, Rhonda A Sparks, and Wayne E Berryhill. 2007. “Diagnosis and treatment of otitis media.” American Family Physician 76 (11): 1650–8. http://www.ncbi.nlm.nih.gov/pubmed/18092706.

R Core Team. 2019. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing. https://www.R-project.org/.

Ricketson, Leah J, Alberto Nettel-Aguirre, Otto G Vanderkooi, Kevin B Laupland, and James D Kellner. 2013. “Factors Influencing Early and Late Mortality in Adults with Invasive Pneumococcal Disease in Calgary, Canada: A Prospective Surveillance Study.” PloS One 8 (10): e71924. https://doi.org/10.1371/journal.pone.0071924.

Robberstad, Bjarne, Carl R. Frostad, Per E. Akselsen, Kari J. Kværner, and Aud K H Berstad. 2011. “Economic evaluation of second generation pneumococcal conjugate vaccines in Norway.” Vaccine 29: 8564–74. https://doi.org/10.1016/j.vaccine.2011.09.025.

Rodrigues, C. M. C., and H. Groves. 2017. “Community-Acquired Pneumonia in Children: the Challenges of Microbiological Diagnosis.” Edited by Colleen Suzanne Kraft. Journal of Clinical Microbiology 56 (3): JCM.01318–17. https://doi.org/10.1128/JCM.01318-17.

Rodrigues, Fernanda, Leon Danon, Begonia Morales-Aza, Paulina Sikora, Valtyr Thors, Muriel Ferreira, Katherine Gould, Jason Hinds, and Adam Finn. 2016. “Pneumococcal Serotypes Colonise the Nasopharynx in Children at Different Densities.” Edited by Jose Melo-Cristino. PLOS ONE 11 (9): e0163435. https://doi.org/10.1371/journal.pone.0163435.

Rosenfeld, Richard M., Jennifer J. Shin, Seth R. Schwartz, Robyn Coggins, Lisa Gagnon, Jesse M. Hackell, David Hoelting, et al. 2016. “Clinical Practice Guideline: Otitis Media with Effusion (Update).” Otolaryngology–Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 154 (1 Suppl): S1–S41. https://doi.org/10.1177/0194599815623467.

Rozenbaum, Mark H, Elisabeth a M Sanders, Albert Jan van Hoek, Angelique G S C Jansen, Arie van der Ende, Germie van den Dobbelsteen, Gerwin D Rodenburg, Eelko Hak, and Maarten J Postma. 2010. “Cost effectiveness of pneumococcal vaccination among Dutch infants: economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines.” BMJ 340 (jun02 1): c2509–c2509. https://doi.org/10.1136/bmj.c2509.

Rozenbaum, M. H., P. Pechlivanoglou, T. S. Werf, J. R. Lo-Ten-Foe, M. J. Postma, and E. Hak. 2013. “The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysis.” European Journal of Clinical Microbiology & Infectious Diseases 32 (3): 305–16. https://doi.org/10.1007/s10096-012-1778-4.

Rubin, Jaime L., Lisa J. McGarry, David R. Strutton, Keith P. Klugman, Stephen I. Pelton, Kristen E. Gilmore, and Milton C. Weinstein. 2010. “Public health and economic impact of the 13-valent pneumococcal conjugate vaccine (PCV13) in the United States.” Vaccine 28 (48): 7634–43. https://doi.org/10.1016/j.vaccine.2010.09.049.

Rudan, Igor, Katherine L O’Brien, Harish Nair, Li Liu, Evropi Theodoratou, Shamim Qazi, Ivana Lukšić, Christa L Fischer Walker, Robert E Black, and Harry Campbell. 2013. “Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries.” Journal of Global Health 3 (1): 010401. https://doi.org/10.7189/jogh.03.010401.

Ruuskanen, O., H. Nohynek, T. Ziegler, R. Capeding, H. Rikalainen, P. Huovinen, and M. Leinonen. 1992. “Pneumonia in childhood: Etiology and response to antimicrobial therapy.” European Journal of Clinical Microbiology & Infectious Diseases 11 (3): 217–23. https://doi.org/10.1007/BF02098083.

Said, Maria a., Hope L. Johnson, Bareng a S Nonyane, Maria Deloria-Knoll, and Katherine L. O′Brien. 2013. “Estimating the Burden of Pneumococcal Pneumonia among Adults: A Systematic Review and Meta-Analysis of Diagnostic Techniques.” Edited by Philip C. Hill. PLoS ONE 8 (4): e60273. https://doi.org/10.1371/journal.pone.0060273.

Sanders, Gillian D., Peter J. Neumann, Anirban Basu, Dan W. Brock, David Feeny, Murray Krahn, Karen M. Kuntz, et al. 2016. “Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses.” JAMA 316 (10): 1093. https://doi.org/10.1001/jama.2016.12195.

Saokaew, Surasak, Ajaree Rayanakorn, David Bin-Chia Wu, and Nathorn Chaiyakunapruk. 2016. “Cost Effectiveness of Pneumococcal Vaccination in Children in Low- and Middle-Income Countries: A Systematic Review.” PharmacoEconomics 34 (12): 1211–25. https://doi.org/10.1007/s40273-016-0439-3.

Sarasoja, Ilona, Jukka Jokinen, Mika Lahdenkari, Terhi Kilpi, and Arto A. Palmu. 2013. “Long-term effect of pneumococcal conjugate vaccines on tympanostomy tube placements.” The Pediatric Infectious Disease Journal 32 (5): 517–20. https://doi.org/10.1097/INF.0b013e31827c9bcc.

Saxena, Sonia, Christina Atchison, Elizabeth Cecil, Mike Sharland, Elizabeth Koshy, and Alex Bottle. 2015. “Additive impact of pneumococcal conjugate vaccines on pneumonia and empyema hospital admissions in England.” Journal of Infection 71 (4): 428–36. https://doi.org/10.1016/j.jinf.2015.06.011.

Schiemann, O., and W. Casper. 1927. “Sind die spezifisch pracipitablen Substanzen der 3 Pneumokokkentypen Haptene?” Zeitschrift Fur Hygiene Und Infektionskrankheiten. https://doi.org/10.1007/BF02176583.

Severens, Johan L., and Richard J. Milne. 2004. “Discounting health outcomes in economic evaluation: the ongoing debate.” Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research 7 (4): 397–401. https://doi.org/10.1111/j.1524-4733.2004.74002.x.

Sgambatti, Sabrina, Ruth Minamisava, Ana Luiza Bierrenbach, Cristiana Maria Toscano, Maria Aparecida Vieira, Gabriela Policena, and Ana Lucia Andrade. 2016. “Early impact of 10-valent pneumococcal conjugate vaccine in childhood pneumonia hospitalizations using primary data from an active population-based surveillance.” Vaccine 34 (5): 663–70. https://doi.org/10.1016/j.vaccine.2015.12.007.

Shioda, Kayoko, Cynthia Schuck-Paim, Robert J. Taylor, Roger Lustig, Lone Simonsen, Joshua L Warren, and Daniel M Weinberger. 2018. “Challenges in estimating the impact of vaccination with sparse data.” Epidemiology (Cambridge, Mass.) 4 (5): 1. https://doi.org/10.1097/EDE.0000000000000938.

Shiri, Tinevimbo, Samik Datta, Jason Madan, Alexander Tsertsvadze, Pamela Royle, Matt J. Keeling, Noel D. McCarthy, and Stavros Petrou. 2017. “Indirect effects of childhood pneumococcal conjugate vaccination on invasive pneumococcal disease: a systematic review and meta-analysis.” The Lancet Global Health 5 (1): e51–e59. https://doi.org/10.1016/S2214-109X(16)30306-0.

Siebert, Uwe, Oguzhan Alagoz, Ahmed M. Bayoumi, Beate Jahn, Douglas K. Owens, David J. Cohen, and Karen M. Kuntz. 2012. “State-Transition Modeling.” Medical Decision Making 32 (5): 690–700. https://doi.org/10.1177/0272989X12455463.

Sigurdsson, Samuel, Elias Eythorsson, Birgir Hrafnkelsson, Helga Erlendsdóttir, Karl G Kristinsson, and Ásgeir Haraldsson. 2018. “Reduction in All-Cause Acute Otitis Media in Children <3 Years of Age in Primary Care Following Vaccination With 10-Valent Pneumococcal Haemophilus influenzae Protein-D Conjugate Vaccine: A Whole-Population Study.” Clinical Infectious Diseases 67 (8): 1213–9. https://doi.org/10.1093/cid/ciy233.

Simonsen, Lone, Robert J Taylor, Cynthia Schuck-Paim, Roger Lustig, Michael Haber, and Keith P Klugman. 2014. “Effect of 13-valent pneumococcal conjugate vaccine on admissions to hospital 2 years after its introduction in the USA: a time series analysis.” The Lancet Respiratory Medicine 2 (5): 387–94. https://doi.org/10.1016/S2213-2600(14)70032-3.

Simonsen, Lone, Robert J Taylor, Yinong Young-Xu, Michael Haber, Larissa May, and Keith P Klugman. 2011. “Impact of Pneumococcal Conjugate Vaccination of Infants on Pneumonia and Influenza Hospitalization and Mortality in All Age Groups in the United States.” mBio 2 (1): e00309–10. https://doi.org/10.1128/mBio.00309-10.

Singleton, Rosalyn J., Robert C. Holman, Randall Plant, Krista L. Yorita, Steve Holve, Edna L. Paisano, and James E. Cheek. 2009. “Trends in otitis media and myringtomy with tube placement among American Indian/Alaska native children and the US general population of children.” The Pediatric Infectious Disease Journal 28 (2): 102–7. https://doi.org/http://dx.doi.org/10.1097/INF.0b013e318188d079.

Sloyer, John L, John H Ploussard, and Virgil M Howie. 1981. “Efficacy of pneumococcal polysaccharide vaccine in preventing acute otitis media in infants in Huntsville, Alabama.” Reviews of Infectious Diseases 3 Suppl: S119–23. http://www.ncbi.nlm.nih.gov/pubmed/7280444.

Smit, Pieter. 1977. “Protective Efficacy of Pneumococcal Polysaccharide Vaccines.” JAMA: The Journal of the American Medical Association 238 (24): 2613. https://doi.org/10.1001/jama.1977.03280250039019.

Smolderen, Kim G. 2010. “Health Care Insurance, Financial Concerns in Accessing Care, and Delays to Hospital Presentation in Acute Myocardial Infarction.” JAMA 303 (14): 1392. https://doi.org/10.1001/jama.2010.409.

Snaebjarnardóttir, Kolfinna, Helga Erlendsdóttir, Ingi Karl Reynisson, Karl Kristinsson, Sandra Halldórsdóttir, Hjördís Hardardóttir, Thórólfur Gudnason, Magnús Gottfredsson, and Ásgeir Haraldsson. 2013. “Bacterial meningitis in children in Iceland, 1975-2010: a nationwide epidemiological study.” Scandinavian Journal of Infectious Diseases 45 (11): 819–24. https://doi.org/10.3109/00365548.2013.817680.

Song, Joon Young, Moon H. Nahm, and M. Allen Moseley. 2013. “Clinical Implications of Pneumococcal Serotypes: Invasive Disease Potential, Clinical Presentations, and Antibiotic Resistance.” Journal of Korean Medical Science 28 (1): 4. https://doi.org/10.3346/jkms.2013.28.1.4.

Sonsuwan, Nuntigar, Patcharin Watcharinyanon, and Kittisak Sawanyawisuth. 2016. “What are the leading causative pathogens in acute otitis media with tympanic membrane perforation?” International Journal of Pediatric Otorhinolaryngology 90 (November): 20–22. https://doi.org/10.1016/j.ijporl.2016.08.021.

Spilsbury, Katrina, Abdul Latif Kadhim, James B Semmens, Francis J Lannigan, Spilsbury K., Kadhim A. L., Semmens J. B., et al. 2006. “Decreasing rates of middle ear surgery in Western Australian children.” Archives of Otolaryngology - Head and Neck Surgery 132 (11): 1216–20. https://doi.org/10.1001/archotol.132.11.1216.

Sternberg, G M. 1882. “A fatal form of septicemia in the rabbit produced by subcutaneous injection of human saliva.” Washington: National Board of Health; U.S. Government Printing Office. https://books.google.is/books?id=YojXubzmx3sC{\&}printsec=frontcover{\&}hl=is{\#}v=onepage{\&}q{\&}f=false.

Stevenson, Mark, Telmo Nunes, Cord Heuer, Jonathon Marshall, Javier Sanchez, Ron Thornton, Jeno Reiczigel, Jim Robison-Cox, Paola Sebastiani, and Peter Solymos. 2018. EpiR: Tools for the Analysis of Epidemiological Data. https://CRAN.R-project.org/package=epiR.

Strutton, David R, Raymond a Farkouh, Stephanie R Earnshaw, Sharon Hwang, Ulrike Theidel, Stathis Kontodimas, Rogier Klok, and Sotiria Papanicolaou. 2012. “Cost-effectiveness of 13-valent pneumococcal conjugate vaccine: Germany, Greece, and The Netherlands.” Journal of Infection 64 (1): 54–67. https://doi.org/10.1016/j.jinf.2011.10.015.

Svensson, Mikael, and Lars Hultkrantz. 2017. “A Comparison of Cost-Benefit and Cost-Effectiveness Analysis in Practice: Divergent Policy Practices in Sweden.” Nordic Journal of Health Economics 5 (2): 41. https://doi.org/10.5617/njhe.1592.

Syrjänen, Ritva K, Kari Auranen, Tuija M Leino, Terhi M Kilpi, and P Helena Mäkelä. 2005. “Pneumococcal acute otitis media in relation to pneumococcal nasopharyngeal carriage.” The Pediatric Infectious Disease Journal 24 (9): 801–6. https://doi.org/10.1097/01.inf.0000178072.83531.4f.

Szucs, Thomas D. 2005. “Health economic research on vaccinations and immunisation practices–an introductory primer.” Vaccine 23 (17-18): 2095–2103. https://doi.org/10.1016/j.vaccine.2005.01.064.

Talbird, Sandra E, Thomas N Taylor, Stefanie Knoll, Carl Richard Frostad, and Sebastián García Martí. 2010. “Outcomes and costs associated with PHiD-CV, a new protein D conjugate pneumococcal vaccine, in four countries.” Vaccine 28 Suppl 6 (November): G23–9. https://doi.org/10.1016/j.vaccine.2010.06.016.

Tawfik, Kareem O., Stacey L. Ishman, Mekibib Altaye, Jareen Meinzen-Derr, and Daniel I. Choo. 2017. “Pediatric Acute Otitis Media in the Era of Pneumococcal Vaccination.” Otolaryngology-Head and Neck Surgery 156 (5): 938–45. https://doi.org/10.1177/0194599817699599.

Taylor, Sylvia, Paola Marchisio, Anne Vergison, Julie Harriague, William P. Hausdorff, and Mark Haggard. 2012. “Impact of pneumococcal conjugate vaccination on otitis media: A systematic review.” Clinical Infectious Diseases 54 (12): 1765–73. https://doi.org/10.1093/cid/cis292.

Teele, D W, J O Klein, and B Rosner. 1989. “Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study.” The Journal of Infectious Diseases 160 (1): 83–94. http://www.ncbi.nlm.nih.gov/pubmed/2732519.

Therneau, Terry M. 2018. Survival: Survival Analysis. https://CRAN.R-project.org/package=survival.

Thornton, Ruth B, Paul J Rigby, Selma P Wiertsema, Pierre Filion, Jennifer Langlands, Harvey L Coates, Shyan Vijayasekaran, Anthony D Keil, and Peter C Richmond. 2011. “Multi-species bacterial biofilm and intracellular infection in otitis media.” BMC Pediatrics 11 (1): 94. https://doi.org/10.1186/1471-2431-11-94.

Thors, Valtyr, Hannah Christensen, Begonia Morales-Aza, Elizabeth Oliver, Paulina Sikora, Ian Vipond, Peter Muir, and Adam Finn. 2018. “High Density Bacterial Nasal Carriage in Children is Transient and Associated With Respiratory Viral Infections – Implications for Transmission Dynamics.” The Pediatric Infectious Disease Journal, November, 1. https://doi.org/10.1097/INF.0000000000002256.

Tillett, W S, M J Cambier, and J E McCormack. 1944. “The Treatment of Lobar Pneumonia and Pneumococcal Empyema with Penicillin.” Bulletin of the New York Academy of Medicine 20 (3): 142–78. https://doi.org/10.7326/0003-4819-60-5-759.

Todberg, Tanja, Anders Koch, Mikael Andersson, Sjurdur F. SF F Olsen, Jørgen Lous, Preben Homøe, W Nystad, et al. 2014. “Incidence of otitis media in a contemporary danish national birth cohort.” Edited by C M Schooling. PloS One 9 (12): e111732. https://doi.org/10.1371/journal.pone.0111732.

Torné, Adoración Navarro, Joana Gomes Dias, Chantal Quinten, Frantiska Hruba, Marta Cecilia Busana, Pier Luigi Lopalco, Andrew J Amato Gauci, and Lucia Pastore-Celentano. 2014. “European enhanced surveillance of invasive pneumococcal disease in 2010: Data from 26 European countries in the post-heptavalent conjugate vaccine era.” Vaccine 32 (29): 3644–50. https://doi.org/10.1016/j.vaccine.2014.04.066.

Tregnaghi, Miguel W. Marcelo, Xavier Sáez-Llorens, Pio López, Hector Abate, Enrique Smith, Adriana Pósleman, Arlene Calvo, et al. 2014. “Efficacy of pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: A double-blind randomized controlled trial.” Edited by Elizabeth Miller. PLoS Medicine 11 (6): e1001657. https://doi.org/10.1371/journal.pmed.1001657.

Troeger, Christopher, Brigette F Blacker, Ibrahim A Khalil, Puja C Rao, Shujin Cao, Stephanie RM Zimsen, Samuel B Albertson, et al. 2018. “Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016.” The Lancet Infectious Diseases 3099 (18): 1–20. https://doi.org/10.1016/S1473-3099(18)30362-1.

Troeger, Christopher, Mohammad Forouzanfar, Puja C Rao, Ibrahim Khalil, Alexandria Brown, Scott Swartz, Nancy Fullman, et al. 2017. “Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015.” The Lancet Infectious Diseases 17 (11): 1133–61. https://doi.org/10.1016/S1473-3099(17)30396-1.

Tsaban, Gal, and Shalom Ben-Shimol. 2017. “Indirect (herd) protection, following pneumococcal conjugated vaccines introduction: A systematic review of the literature.” Vaccine 35 (22): 2882–91. https://doi.org/10.1016/j.vaccine.2017.04.032.

Tsigrelis, Constantine, Imad M. Tleyjeh, Brian D. Lahr, Lisa M. Nyre, Abinash Virk, and Larry M. Baddour. 2008. “Decreases in Case‐Fatality and Mortality Rates for Invasive Pneumococcal Disease in Olmsted County, Minnesota, during 1995–2007: A Population‐Based Study.” Clinical Infectious Diseases 47 (11): 1367–71. https://doi.org/10.1086/592970.

Tuomanen, Elaine I., Robert Austrian, and H. Robert Masure. 1995. “Pathogenesis of Pneumococcal Infection.” Edited by Franklin H. Epstein. New England Journal of Medicine 332 (19): 1280–4. https://doi.org/10.1056/NEJM199505113321907.

Usonis, Vytautas, Teresa Jackowska, Sigita Petraitiene, Alicja Sapala, Andrea Neculau, Izabella Stryjewska, Raghavendra Devadiga, Monica Tafalla, and Katsiaryna Holl. 2016. “Incidence of acute otitis media in children below 6 years of age seen in medical practices in five East European countries.” BMC Pediatrics 16 (1): 108. https://doi.org/10.1186/s12887-016-0638-2.

VanderWeele, Tyler J., and Peng Ding. 2017. “Sensitivity Analysis in Observational Research: Introducing the E-Value.” Annals of Internal Medicine 167 (4): 268–74. https://doi.org/10.7326/M16-2607.

Van Dyke, Melissa K., Jean-Yves Pirçon, Robert Cohen, Shabir A. Madhi, Andrés Rosenblüt, Mercedes Macias Parra, Khalid Al-Mazrou, et al. 2017. “Etiology of Acute Otitis Media in Children Less Than 5 Years of Age.” The Pediatric Infectious Disease Journal 36 (3): 274–81. https://doi.org/10.1097/INF.0000000000001420.

Venekamp, Roderick P, Paul Mick, Anne GM Schilder, and Desmond A Nunez. 2018. “Grommets (ventilation tubes) for recurrent acute otitis media in children.” Cochrane Database of Systematic Reviews (4):CD0047 (4): CD004741. https://doi.org/10.1002/14651858.CD012017.pub2.

Vergison, Anne, Ron Dagan, Adriano Arguedas, Jan Bonhoeffer, Robert Cohen, Ingeborg DHooge, Alejandro Hoberman, et al. 2010. “Otitis media and its consequences: beyond the earache.” The Lancet Infectious Diseases 10 (3): 195–203. https://doi.org/10.1016/S1473-3099(10)70012-8.

Vesikari, Timo, Aino Forsten, Ilkka Seppa, Tarja Kaijalainen, Taneli Puumalainen, Anu Soininen, Magali Traskine, et al. 2016. “Effectiveness of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D-conjugated vaccine (PHiD-CV) against carriage and acute otitis media-a double-blind randomized clinical trial in Finland.” Journal of the Pediatric Infectious Diseases Society 5 (3). https://doi.org/10.1093/jpids/piw010.

Vlastarakos, Petros V., Thomas P. Nikolopoulos, Stavros Korres, Evangelia Tavoulari, Antonios Tzagaroulakis, and Eleftherios Ferekidis. 2007. “Grommets in otitis media with effusion: the most frequent operation in children. But is it associated with significant complications?” European Journal of Pediatrics 166 (5): 385–91. https://doi.org/10.1007/s00431-006-0367-x.

Vojtek, Ivo, Marcus Nordgren, and Bernard Hoet. 2017. “Impact of pneumococcal conjugate vaccines on otitis media: A review of measurement and interpretation challenges.” International Journal of Pediatric Otorhinolaryngology 100 (September): 174–82. https://doi.org/10.1016/j.ijporl.2017.07.009.

Vooren, K van de, S Duranti, A Curto, and L Garattini. 2014. “Cost effectiveness of the new pneumococcal vaccines: a systematic review of European studies.” Pharmacoeconomics 32: 29–45. https://doi.org/10.1007/s40273-013-0113-y.

Wagner, A K, S B Soumerai, F Zhang, and D Ross-Degnan. 2002. “Segmented regression analysis of interrupted time series studies in medication use research.” Journal of Clinical Pharmacy and Therapeutics 27 (4): 299–309. http://www.ncbi.nlm.nih.gov/pubmed/12174032.

Waight, Pauline A., Nicholas J. Andrews, Shamez N. Ladhani, Carmen L. Sheppard, Mary P. E. E Slack, and Elizabeth Miller. 2015. “Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: An observational cohort study.” The Lancet Infectious Diseases 15 (5): 535–43. https://doi.org/10.1016/S1473-3099(15)70044-7.

Walker, Damian G, Raymond Hutubessy, and Philippe Beutels. 2010. “WHO Guide for standardisation of economic evaluations of immunization programmes.” Vaccine 28 (11): 2356–9. https://doi.org/10.1016/j.vaccine.2009.06.035.

Wasserman, Matt, Heather L. Sings, Dylan Jones, Sarah Pugh, Margaret Moffatt, and Raymond Farkouh. 2018. “Review of vaccine effectiveness assumptions used in economic evaluations of infant pneumococcal conjugate vaccine.” Expert Review of Vaccines 17 (1): 71–78. https://doi.org/10.1080/14760584.2018.1409116.

Watson, David A, Daniel M Musher, James W Jacobson, and Jan Verhoef. 1993. “A Brief History of the Pneumococcus in Biomedical Research: A Panoply of Scientific Discovery Description of the Organism and Demonstration of Its Virulence.” Clinical Infectious Diseases 17: 913–24. https://doi.org/10.1093/clinids/17.5.913.

Weichselbaum, A. 1886. “Ueber die Aetiologie der acuten Lungen-und Rippenfellentzundungen.” Medizinische Jahrbücher., 483–554.

Weinberger, Daniel M., Zitta B. Harboe, Elisabeth A. M. Sanders, Moses Ndiritu, Keith P. Klugman, Simon Rückinger, Ron Dagan, et al. 2010. “Association of Serotype with Risk of Death Due to Pneumococcal Pneumonia: A Meta‐Analysis.” Clinical Infectious Diseases 51 (6): 692–99. https://doi.org/10.1086/655828.

Weinberger, Daniel M, Zitta B Harboe, Cécile Viboud, Tyra G Krause, Mark Miller, Kåre Mølbak, and Helle B Konradsen. 2013. “Pneumococcal disease seasonality: incidence, severity, and the role of influenza activity.” The European Respiratory Journal, September, 1–19. https://doi.org/10.1183/09031936.00056813.

Weinberger, Daniel M, Richard Malley, and Marc Lipsitch. 2011. “Serotype replacement in disease after pneumococcal vaccination.” Lancet 378 (9807): 1962–73. https://doi.org/10.1016/S0140-6736(10)62225-8.

Weinstein, Milton C., Bernie O’Brien, John Hornberger, Joseph Jackson, Magnus Johannesson, Chris McCabe, and Bryan R. Luce. 2003. “Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices—Modeling Studies.” Value in Health 6 (1): 9–17. https://doi.org/10.1046/j.1524-4733.2003.00234.x.

Weinstein, Milton C., Edmond L. Toy, Eileen A. Sandberg, Peter J. Neumann, John S. Evans, Karen M. Kuntz, John D. Graham, and James K. Hammitt. 2001. “Modeling for Health Care and Other Policy Decisions: Uses, Roles, and Validity.” Value in Health 4 (5): 348–61. https://doi.org/10.1046/j.1524-4733.2001.45061.x.

Weisfelt, Martijn, Diederik van de Beek, Lodewijk Spanjaard, Johannes B Reitsma, and Jan de Gans. 2006. “Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series.” The Lancet. Neurology 5 (2): 123–9. https://doi.org/10.1016/S1474-4422(05)70288-X.

Whitney, C G, T Pilishvili, Monica M Farley, W Schaffner, Allen S Craig, R Lynfield, A C Nyquist, et al. 2006. “Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study.” Lancet 368: 1495–1502. https://doi.org/S0140-6736(06)69637-2 [pii]\r10.1016/S0140-6736(06)69637-2.

Wilkinson, Thomas, Mark J. Sculpher, Karl Claxton, Paul Revill, Andrew Briggs, John A. Cairns, Yot Teerawattananon, et al. 2016. “The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought.” Value in Health 19 (8): 921–28. https://doi.org/10.1016/j.jval.2016.04.015.

Winslow, C.-E. E, Jean Broadhurst, R. E. Buchanan, C Krumwiede, L. A. Rogers, and G. H Smith. 1920. “The Families and Genera of the Bacteria: Final Report of the Committee of the Society of American Bacteriologists on Characterization and Classification of Bacterial Types.” Journal of Bacteriology 5 (3): 191–229. https://doi.org/10.1086/278854.

World Health Organization Pneumonia Vaccine Trial Investigators’ Group. 2001. “Standardization of interpretation of chest radiographs for the diagnosis of pneumonia in children.” Geneva: World Health Organization. http://www.who.int/iris/handle/10665/66956.

Wright, AlmrothE., W. Parry Morgan, L Colebrook, and R. W. Dodgson. 1914. “Observations on prophylactic inoculation against pneumococcus infections and on the results which have been achieved by it.” The Lancet 183 (4715): 87–95. https://doi.org/10.1016/S0140-6736(01)56449-1.

Wu, David Bin-Chia, Nathorn Chaiyakunapruk, Huey-Yi Chong, and Philippe Beutels. 2015. “Choosing between 7-, 10- and 13-valent pneumococcal conjugate vaccines in childhood: A review of economic evaluations (2006–2014).” Vaccine 33 (14): 1633–58. https://doi.org/10.1016/j.vaccine.2015.01.081.

Yagupsky, P, N Porat, D Fraser, F Prajgrod, M Merires, L McGee, K P Klugman, and R Dagan. 1998. “Acquisition, Carriage, and Transmission of Pneumococci with Decreased Antibiotic Susceptibility in Young Children Attending a Day Care Facility in Southern Israel.” Journal of Infectious Diseases 177 (4): 1003–12. https://doi.org/10.1086/515239.

Youngster, Ilan, Jerry Avorn, Valeria Belleudi, Anna Cantarutti, Javier Díez-Domingo, Ursula Kirchmayer, Byung-Joo Park, et al. 2017. “Antibiotic Use in Children – A Cross-National Analysis of 6 Countries.” The Journal of Pediatrics 182 (March): 239–244.e1. https://doi.org/10.1016/j.jpeds.2016.11.027.

Zhou, Fangjun, Abigail Shefer, Yuan Kong, and J Pekka Nuorti. 2008. “Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997-2004.” Pediatrics 121 (2): 253–60. https://doi.org/10.1542/peds.2007-0619.

Zhou, F., Abigail Shefer, J. Wenger, M. Messonnier, L. Y. Wang, A. Lopez, M. Moore, T. V. Murphy, M. Cortese, and L. Rodewald. 2014. “Economic Evaluation of the Routine Childhood Immunization Program in the United States, 2009.” PEDIATRICS 133 (4): 577–85. https://doi.org/10.1542/peds.2013-0698.

Þórðardóttir, Ásgerður, Helga Erlendsdóttir, Bryndís Sigurðardóttir, Hjördís Harðardóttir, Ingi Karl Reynisson, Magnús Gottfreðsson, and Sigurður Guðmundsson. 2014. “Bacterial meningitis in adults in Iceland, 1995–2010.” Scandinavian Journal of Infectious Diseases 46 (5): 354–60. https://doi.org/10.3109/00365548.2014.880184.